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ABSTRACT OF DISSERTATION
Fetal alcohol spectrum disorder results from developmental exposure to
ethanol. Although many organ systems are targeted by this teratogen, the
central nervous system is exquisitely sensitive. Children with this disease often
present with behavioral disorders as well as impairments in learning and
memory. Ethanol exposure affects developmental processes throughout
pregnancy; however, the third trimester-equivalent has demonstrated heightened
sensitivity. Although the mechanism of action(s) of ethanol remains unknown,
studies suggest that impairments in glutamatergic signaling and synaptic
plasticity during the third trimester-equivalent period of development lead to
alterations in synaptic formation and refinement. However, little is known about
the developmental effects of ethanol in the CA1 hippocampal region, a brain
region often studied in the context of learning and memory.
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Studies presented in this dissertation address the acute and chronic
effects of ethanol during the third trimester-equivalent period. First,
characterization of the acute effects of ethanol demonstrated postsynaptic
inhibition of both NMDA receptor (NMDAR) and AMPA receptor (AMPAR)
mediated synaptic responses, as well as the inhibition of long-term potentiation
(LTP) induction. Then, an in vivo repeated ethanol exposure paradigm was used
to mimic maternal drinking during this period. In contrast to the effects of acute
ethanol exposure, repeated exposure did not affect AMPAR- or NMDARmediated synaptic strength or glutamate release; however, it impaired LTP
expression and/or maintenance. Lastly, repeated in vivo third trimesterequivalent ethanol exposure did not affect expression of Ca2+-permeable
AMPARs, or induce tolerance to the acute inhibitory effects of ethanol.
Studies in this dissertation add to a growing body of evidence indicating
that significant differences exist between the effects of ethanol on the developing
versus the mature brain. Furthermore, studies presented here support the notion
that ethanol-mediated impairments in synaptic plasticity mechanisms during the
third trimester-equivalent developmental period could lead to inappropriate wiring
of neuronal circuitry, and set the stage for the long term deficits observed in
children with fetal alcohol spectrum disorder.
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1. Introduction
Overview of Fetal Alcohol Syndrome and Fetal Alcohol
Spectrum Disorders
Maternal ethanol (EtOH) use during pregnancy can lead to a broad range
of clinical findings in children ranging from central nervous system impairments,
such as learning and memory deficits, to full-blown fetal alcohol syndrome (FAS).
The clinical hallmarks required for a diagnosis of FAS include characteristic facial
dysmorphology, growth retardation and impaired central nervous system function
(Sokol et al., 2003). Clinical cases that do not meet the diagnostic criteria for FAS
are described under the umbrella term, fetal alcohol spectrum disorder (FASD)
(Sokol et al., 2003; Jones and Smith, 1973). The prevalence of children with
FASD in the U.S. was recently estimated to be 2-5%, whereas the prevalence of
children with FAS is estimated to be 0.2-0.7% (Sokol et al., 2003; May et al.,
2009).
In the general population, the majority of women stop drinking when they
become pregnant (Muhuri and Gfroerer, 2009). However, a recent study by the
National Survey on Drug Use and Health (2002-2006) found that 10.5% of
women report EtOH use during pregnancy, and 3.2% engage in binge drinking
(Muhuri and Gfroerer, 2009). Although the percentage of women reporting
drinking decreases as pregnancy progresses, a significant portion continue to do
so through the third-trimester; during this trimester, 6.9% report consuming
EtOH, and 1% engage in binge drinking (Muhuri and Gfroerer, 2009).
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Although a substantial percentage of women drink during pregnancy, not
all have children afflicted by FAS or FASD (Maier and West, 2001). Factors that
influence the consequences of maternal EtOH consumption and predict severity
are: maternal drinking patterns (frequency and amount), metabolism, genetic
susceptibility, timing of consumption during pregnancy, and increased
vulnerability of some brain regions during certain stages of development (Maier
and West, 2001; Livy et al., 2003a). In addition, EtOH use during pregnancy is
often associated with other factors (i.e. poverty, poor nutrition/prenatal care,
other drug use, etc) that enhance the neuroteratogenic effects of EtOH (Goodlett
et al., 2005).
The clinical deficits associated with FAS and FASD are likely mediated by
multiple mechanisms that depend on the timing of exposure. For example, the
impairments in craniofacial features of children with FAS (i.e. short palpebral
fissures, flat/indistinct philtrum, thin upper lip) have been ascribed to impaired
cellular migration, including that of neural crest cells, during the first trimester
period when organogenesis occurs (Goodlett and Horn, 2001). Exposure during
the second trimester has also been associated with abnormalities in neuronal
migration as well as cell survival, leading to changes in brain region volume
(Goodlett et al., 2005). Exposure during the third-trimester has been linked to
impaired neuronal survival/apoptosis, synaptic formation and synaptic
refinement; these impairments are thought to be, in part, responsible for longterm deficits in learning, memory and other cognitive processes (Berman and
Hannigan, 2000; Medina and Krahe, 2008; Olney, 2004). One brain region
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known for its role in certain types of learning and memory is the hippocampus,
which has been shown to be sensitive to the deleterious consequences of
developmental EtOH exposure. The rest of this document will focus on the
developmental effects of EtOH in the context of impaired hippocampal function.

Learning and memory alterations in children afflicted by FASD
and in animal models of this disorder
Behavioral and cognitive impairments are a hallmark of FAS and FASD.
Many brain regions are required for higher cognitive function, such as learning
and memory, and have been shown to be targets of the teratogenic effects of
EtOH. Several studies have assessed learning and memory in children with
prenatal EtOH exposure, and found deficits thought to be attributable, in part, to
impaired hippocampal function.
Hamilton and colleagues (2003) tested 8 adolescent males (9.5-16.5 y/o)
diagnosed with FAS and 8 matched-controls in a virtual Morris water maze task,
which is thought to probe hippocampal function. Children with FAS performed
significantly worse in navigating to the hidden platform in the virtual maze;
however, there was no difference in navigating to a cued platform, suggesting
that deficits were attributable to the hippocampus, and not other brain regions
controlling motor performance or motivation during the task (Hamilton et al.,
2003). In a study by Uecker and Nadel (1998), 30 children, 15 with FAS and 15
matched controls (11 male, 4 female; average age 10 ± 2.3 y/o) were assessed
for performance on object recognition/location tasks. Briefly, subjects were given
cards of a dog, a kitten playing the guitar, a plant being watered, etc, which were
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arranged on a large book. They were asked to remember one of the the cards
and to locate it in the book. Both control and children with FAS could remember
the cards; however, children with FAS demonstrated significant impairments in
location recall (immediate and after 24 hrs) suggestive of hippocampal damage
(Uecker and Nadel, 1998). Additional studies are summarized in Table 1.1.
Table 1.1. Summary of learning and memory deficits observed in children with prenatal EtOH exposure

Author (year)

Age
(years)

Number of
prenatally
exposed
subjects

Mattson et al. 1998
Steinhausen et al. 1982
Olson et al. 1998
Uecker and Nadel 1996
Uecker and Nadel 1998
Hamilton et al. 2003

5-16
3-15.5
14-16
10 ± 2.3
10 ± 2.3
9.5-16.5

25
49
226
15
15
8

Main finding
Global-local visuospatial abnormalities
Deficits in spatial relationships
Deficits in visuospatial skills
Spatial deficits and delayed recall
Deficits in spatial recall
Deficits in virtual water maze

Animal models have been developed to further our understanding of the
pathophysiology of FASD. However, several challenges exist when attempting to
model this human disorder. Maternal EtOH consumption varies in terms of
timing, dose, duration, and amount; therefore, a single exposure paradigm
cannot accurately model human maternal EtOH consumption patterns.
Therefore, investigators have used several exposure paradigms to mimic this
disease. In spite of this, the overwhelming consensus is that animal models of
FAS and FASD accurately recapitulate deficits in higher cognitive function
(Berman and Hannigan, 2000). These include learning and memory deficits
attributed to impaired hippocampal function.
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Savage and colleagues (2002) found that prenatal EtOH exposure (30-80
mg/dL) in rats (which models the human first and second trimester) led to
impaired learning of a new platform location in the Morris water maze at
postnatal days (P) 180-220 (Savage et al., 2002). Studies in the radial arm maze
demonstrated impaired spatial learning in P60 rats gestationally exposed to
EtOH (blood alcohol level = 170 mg/dL on gestational day 18) (Reyes et al.,
1989). In addition, administration of 6g/Kg of EtOH on P6 (third trimesterequivalent period) resulted in impaired performance in a serial spatial
discrimination reversal learning task in a t-maze at P40-42 (Thomas et al., 2002).
Studies with animal models of the effect of developmental EtOH exposure on
learning and memory are summarized in Table 1.2. Collectively, these studies
indicate that developmental EtOH exposure leads to persistent impairments in
hippocampal function, leading to alterations in learning and memory.
Table 1.2. Effects of prenatal or neonatal EtOH exposure on tests of learning and memory

Author (year)

Trimesterequivalent
exposure
period

Animal
model

Type of behavioral
test

Effect

Lochry and Riley (1980)
Zimmerberg et al. (1991)
Blanchard et al. (1987)
Goodlett et al. (1997)
Savage et al. (2002)
Reyes et al. (1989)
Thomas et al. (2002)

1st, 2nd
1st, 2nd
1st, 2nd
3rd
1st, 2nd
1st, 2nd
3rd

Rat
Rat
Rat
Rat
Rat
Rat
Rat

T-maze
T-maze
Morris water maze
Morris water maze
Morris water maze
Radial arm maze
T-maze

impaired spatial acquisition
impaired reference memory
impaired spatial acquisition
impaired spatial acquisition
impaired “one trial” learning
impaired spatial memory
impaired reversal learning

Many mechanisms of action of EtOH on the developing brain have been
proposed and some of these may apply to the hippocampus. These include
disrupted cellular energetics, cell migration, altered cellular acquisition and
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timing, cell-cell interactions, cellular damage/apoptosis, and alterations in
neuronal signaling (Goodlett et al., 2005; Goodlett and Horn, 2001). Although
several mechanisms have been proposed, those that mediate persistent
impairments in learning and memory are not fully understood. It is clear that
EtOH affects multiple cellular processes during different stages of hippocampal
development and several of these processes will be discussed in the next
section.

Hippocampal development: effects of EtOH
In rats, hippocampal development begins early during the second
trimester-equivalent and continues through the third trimester-equivalent
(Kostovic et al., 1989; Andersen et al., 2007). As previously alluded to, rodent
gestation mimics the first two human trimesters, whereas the first 10-12 rodent
postnatal days mimic the gestational equivalent to the human third-trimester.
Fig 1.1 provides an overview of critical neurodevelopmental events in humans
and rats. Figure 1.2 shows brain growth as a function of gestational age in
multiple mammalian species, emphasizing the period termed the “brain growth
spurt”, which has shown heightened sensitivity to teratogens, especially EtOH
(Livy et al., 2003a; Berman and Hannigan, 2000; Thomas et al., 2002; Galindo
and Valenzuela, 2006; Krahl et al., 1999; Thomas et al., 2008; Olney et al., 2001;
O'Leary-Moore et al., 2006; Hunt et al., 2009; Tsuji et al., 2008). The effects of
EtOH on the different phases of hippocampal development will be discussed in
more detail below.
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Neurogenesis

Growth

Dendrites

Local
axons

Spine acquisition

Synapse formation

Glutamate

GABA

1st & 2nd Trimesters
E0

E10

3rd Trimester
Birth

P12

Human
Rat

Age (days)
Figure 1.1.Time course of rat and human development showing significant neurodevelopmental
events. Adapted from Ben-Ari (2002).

7

% of adult weight
Figure 1.2. Brain growth spurt in several mammalian species showing the increase brain weight
as a function of age. Units for x-axis vary by species, and are days for rat and guinea pig, 2 days
for rabbit, 4 days for monkey, 5 days for sheep, weeks for pig, and months for humans. Adapted
from Cudd, T. (2005).

Neurogenesis and neuronal migration
Stem cells from the ventricular germinative layer located between the
ventricular wall and the unformed CA1 region migrate along two radial glial
bundles (supragranular bundle and fimbral bundle) to eventually lead to the
formation of the hippocampus proper (Nakahira and Yuasa,
asa, 2005; Barry et al.,
2008). In rats, stem cells differentiate into pyramidal cells at embryonic day(s)
(E) 16-21, with peak generation occurring around E17 for CA3 neurons, and E1819 for CA1 neurons (Andersen et al., 2007). Although CA3 neurons are
generated earlier than CA1 pyramidal neurons— because of the longer distance
they must travel to their final location relative to CA1 pyramidal neurons—the
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CA3 region develops distinct layers after the CA1 region (Andersen et al., 2007).
Early pyramidal cell layers contain 6-10 neuronal rows, which gradually decrease
to 2-3 rows as the animal matures (Andersen et al., 2007). In the human, distinct
layers of the hippocampal formation have been observed around the 16th week of
embryonic development (Kostovic et al., 1989). In contrast to the generation of
pyramidal cells, approximately 85% of the dentate granule cells are generated
after birth in rats (Andersen et al., 2007). These neurons originate from a
germinative layer of stem cells in the hilus (Andersen et al., 2007). The period of
neurogenesis in this region is considerably longer, continuing into adulthood
(Andersen et al., 2007).
GABAergic interneuron generation in the strata oriens and radiatum,
molecular layer of the hilus, and lacunosum-moleculare have been observed
approximately 1 day before the principle cells that will eventually form the CA1-3,
and dentate gyrus (Andersen et al., 2007). It has been suggested that these
early-generated interneurons guide future circuit formation, as will be discussed
in more detail below (Andersen et al., 2007).
To the best of my knowledge, studies that directly address the effects of
EtOH exposure on hippocampal cell migration are lacking; however, deficits have
been shown in the cortex and cerebellum with both in vitro and in vivo EtOH
exposure paradigms (Kumada et al., 2006; Miller, 1993). Furthermore, studies
have shown long-lasting decreased neuronal number in the CA1 and dentate
gyrus as a result of prenatal EtOH exposure in rats, suggesting impaired
neurogenesis (Miller, 1995). Postnatal EtOH exposure did not affect neuronal
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number, unless EtOH concentrations exceeded 300 mg/dL (Miller, 1995).
Interestingly, postnatal EtOH exposure (~220 mg/dL) led to increased cell
numbers in the dentate gyrus, suggesting possible region, dose, and timing

Initiation Outgrowth

Arborization

Spine
Formation

Limited/ceased
growth

Figure 1.3. Milestones in dendritic development. Adapted from Scott and Luo (2001).

specific effects of developmental EtOH exposure (Miller, 1995).

Neuronal polarization; formation of axons and dendrites
Once neurons reach their destination, a process of polarization occurs
where immature processes begin to form, eventually giving rise to axons and
dendrites (Dotti et al., 1988). Dendritic development occurs in a series of
regulated steps as shown in Fig 1.3. First, immature neurons develop polarity
from which immature dendritic outgrowth occurs. Next, dendrites extend (often
cue directed) and branch at specified intervals. This is followed by the
generation of dendritic spines where the majority of excitatory synapses will be
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established. Lastly, these dendrites reach their mature shape, and are
characterized by defined borders and little further growth (Scott and Luo, 2001;
Yoshimura et al., 2006).
Studies have shown that dendritic outgrowth is affected by developmental
EtOH exposure. In the CA1 hippocampal region, a prenatal through lactation
EtOH exposure paradigm (5.5g/Kg/day) resulted in blunted basilar dendrites in
14 day old mice (Davies and Smith, 1981). In addition, Ferrer and colleagues
(1988) showed a reduction in dendritic spines in CA1-3 pyramidal cells in P15
offspring gestationally exposed to a 35% liquid EtOH diet; however, this effect
was not present in P90 animals, suggesting possible compensatory actions
(Ferrer et al., 1988). In a case report of a 4 month-old child born to an alcoholdependent mother, there were reduced dendritic spines in cortical layer 5
pyramidal cells (Ferrer and Galofre, 1987). These data indicate that EtOH
affects dendritic development, leading to improper formation of excitatory
synaptic connections at dendritic spines (Haas et al., 2006; Cline and Haas,
2008; Fiala et al., 1998; Zhou et al., 2004; McKinney, 2005).
Axonal and dendritic development begins with immature neuronal
projections called lamellipodia (Stage 1; Fig. 1.4). These projections then further
develop into several protrusions called neurites, which will eventually give rise to
an axon and several dendrites (Stage 2). However, at this point it is not
determined which neurite will become the axon. As development progresses, the
axon develops and its extension is guided by the growth cone (Stage 3). Further
maturation of the remaining neurites occurs, and these will eventually become
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the dendrites (Stage 4). This is then followed by formation of synaptic
connections and incorporation into the neuronal network (Stage 5) (Dotti et al.,
1988; Scott and Luo, 2001; Yoshimura et al., 2006; Miller, 2006).
Although not much is known about the effects of developmental EtOH
exposure on hippocampal axonal projections, the consensus from studies to-date
is that EtOH induces hypertrophy of these processes (Miller, 2006). Mossy fiberto-CA3 pyramidal neuron synapses were found to be disorganized and have
abnormal positioning in adult rats prenatally exposed to EtOH (West et al., 1981).
In addition, prenatal EtOH exposure was shown to increase neuronal projections
from the somatosensory cortex to the spinal cord in 3-4 month-old rats (Miller,
2006; Miller, 1987). However, children prenatally exposed to EtOH often exhibit
decreased area in the corpus callosum, which contains a large density of
cerebral cortical axons that cross into the contralateral hemisphere, suggesting
that EtOH can preferentially affect this axonal population (Sowell et al., 2001).

Synaptogenesis
Cue directed signals (such as, NETRIN-1 and Sema3C) guide the axonal
growth cone to the site of a potential synaptic connection (Miller, 2006; Sanes
and Lichtman, 2001; Munno and Syed, 2003; Steup et al., 2000). In preparation
for this partnership, partially differentiated pre- and postsynaptic components can
be distinguished (Munno and Syed, 2003; Ahmari et al., 2000; Nimchinsky et al.,
2002). Immature presynaptic “packets” contain a heterogeneous mixture of
synaptic machinery molecules, including VAMP (synaptobrevin), Ca2+ channels,
endoplasmic reticulum, and vesicular proteins (Ahmari et al., 2000).
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Postsynaptic precursors have been shown to contain functional neurotransmitter
receptors and cell-cell interaction molecules (Munno and Syed, 2003). These
rudimentary synaptic components then make physical contact, and factors that
help synaptic stabilization (such as neurotransmitters and agrin) are released
from the presynaptic terminal (Munno and Syed, 2003). In addition to chemical
signaling, cell adhesion, and cell-cell interacting molecules (i.e. Ephrin, Ncadherins, neurexins/neuroligins) act to further stabilize synaptic connections
(Miller, 2006; Munno and Syed, 2003), in part, by facilitating the recruitment of
scaffolding proteins such as PSD-95 or Sap-102, which recruit signaling
molecules and glutamate receptors such as NMDA and/or AMPA receptors, as
discussed in more detail below (Miller, 2006; Munno and Syed, 2003; Elias et al.,
2008). Although synapse formation has been shown to occur in the absence of
transmitter release, this process is required for synapse stabilization and
maintenance (Verhage et al., 2000).
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Stage 1
Lamellipodia
formation

Stage 2

Growth cone

Immature neurite
formation
Immature neurites

Stage 3
Single axon
formation

Single axon

Immature neurites

Stage 4
Multiple dendrite
formation
Multiple dendrites

Stage 5
Further maturation

Multiple dendrites and network incorporation
Figure 1.4. Stages of development neuronal polarization and development. From Yoshimura
(2006).
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Synaptic stabilization and refinement
Early glutamatergic synaptic transmission
Nascent glutamatergic synaptic connections are classically thought of
those containing NMDARs and lacking AMPA receptors (AMPARs). These
glutamatergic synapses are considered silent because they are inactive at rest
due to Mg2+ block of NMDARs that cannot be relieved as a consequence of the
absence of AMPARs. Silent synapses have been identified throughout the
developing brain, they and decrease with maturation (reviewed in Kerchner and
Nicoll, 2008). In the neonatal rat hippocampal CA1, region almost all
glutamatergic synapses are silent at birth (P0); over the course of the first two to
three postnatal weeks, these synapses gradually acquire AMPARs (Durand et
al., 1996). Studies have suggested that NMDARs play an active role in the
maintenance of these silent synapses, by preventing functional AMPARs at the
synapse (Hall et al., 2007; Adesnik et al., 2008). One proposed mechanism by
which this occurs is the negative regulation of transmembrane AMPAR regulatory
protein (TARP) expression (Hall et al., 2007). In addition, NMDARs have been
shown to negatively regulate AMPAR transcription and translation, and also to
increase AMPAR degradation (reviewed in Hall and Ghosh, 2008). Synapse
silence is considered a mechanism that preserves the synapse in a naïve state
until correlated activity selectively turns it on, as discussed in more detail below.
Controversy has arisen as to the correct “location” of silent synapses
during development. Evidence for postsynaptic silent synapses comes from
electrophysiological recordings in the CA1 region of the hippocampus in neonatal
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rats. Before a high-frequency induction paradigm, the only observable currents
were NMDAR-mediated; after the induction paradigm, both NMDAR- and
AMPAR-mediated currents could be observed (Durand et al., 1996).
Immunogold labeling studies of glutamatergic synapses also showed a
developmental increase in AMPARs with little change in NMDARs (Petralia et al.,
1999). In addition, laser-induced glutamate uncaging experiments—performed in
the presence of the Na+ channel inhibitor tetrodotoxin to block action potentialdependent transmitter release—showed that glutamatergic synapses in layers
2/3 of the rats cortex had only NMDAR responses and these acquired AMPARs
as development progressed (Busetto et al., 2008).
Evidence from cultured neuron and slice electrophysiology experiments
suggests that presynaptic mechanisms can also explain the silent synapse
phenomenon. Using immunohistochemical and electrophysiological methods,
studies with hippocampal neurons in culture demonstrated that AMPARs and
NMDARs were present in newly formed synapses (Cottrell et al., 2000; Friedman
et al., 2000). In addition, spontaneous excitatory postsynaptic currents (sEPSCs)
mediated by both NMDARs and AMPARs were detected in hippocampal slices
from neonatal rats (Groc et al., 2002). Moreover, studies have shown that
glutamate is released into immature synapses at a low level that is sufficient to
activate only the high-affinity NMDARs but not AMPARs, resulting in silent
synapses from the functional stand point (Choi et al., 2000). Silent synapses
demonstrated AMPAR-mediated responses when methods to either increase the
probability of glutamate release or glutamate actions at the AMPAR (i.e. paired-
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pulse stimulation, increased temperature, or cyclothiazide application to inhibit
desensitization) were used, suggesting that silent synapses express both
AMPARs and NMDARs (Gasparini et al., 2000).
In addition to the above-described pre- and postsynaptic mechanisms of
synapse silence, another mechanism of synapse inactivation involves the
activity-dependent removal of AMPARs that exist in a “labile” state. Studies
supporting this in neonatal animals showed that test frequencies typically used to
induce evoked responses (0.05-1 Hz) caused a rapid decrease in the magnitude
of AMPAR-mediated responses, thus suggesting that synapses are born with
both NMDARs and AMPARs and that the AMPARs exist in a labile state that can
be controlled in an activity-dependent manner (Xiao et al., 2004). Interestingly,
when relatively prolonged interruption of these test-pulses (~40 min) occur,
AMPAR-mediated field responses return to initial levels (Abrahamsson et al.,
2007).
Only one study has addressed the effects of EtOH on silent synapses in
the developing brain. Recordings from P3-4 rat pups exposed prenatally to EtOH
(dam blood ethanol levels 0.08 g/dL) demonstrated decreased silent synapses in
the CA1 hippocampal region (Mameli and Valenzuela. Unpublished
observations). Although the mechanism remains unexplored, acute EtOH
application was shown to strengthen AMPAR transmission in a pregnenolone
sulfate (PREGS)-like neurosteroid manner in the CA1 hippocampal region of P34 rat pups (Mameli and Valenzuela, 2006). In addition, the levels of PREGS
have been shown to be elevated by the same prenatal EtOH exposure paradigm
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used for the silent synapses studies in brains of rat pups (up to P5) (Caldeira et
al., 2004). These results suggest that EtOH exposure during the third trimesterequivalent period can prematurely stabilize synaptic connections, potentially
limiting network connectivity (Voigt et al., 2005).
Besides studies of Mameli and Valenzuela, relatively few studies have
addressed the acute effects of EtOH on NMDAR and AMPAR function in the
hippocampal region during the third trimester-equivalent period. In mature
animals, it is well documented that EtOH generally leads to inhibition of
NMDARs, whereas AMPARs are relatively insensitive. Table 1.4 summarizes
studies of EtOH on NMDAR- and AMPAR-mediated responses in the
hippocampus. Studies from our laboratory have indicated that the effects of
EtOH on glutamatergic function in the hippocampus are developmentally
regulated, thus suggesting a critical period of vulnerability to EtOH-mediated
insults (Mameli et al., 2005; Valenzuela et al., 2007).
Table 1.3. Summary of the effects of EtOH on AMPAR- and NMDAR-mediated responses in the
mature and developing hippocampus

Receptor

EtOH Conc.
Effect (mM)

Brain
region

Rodent Age

AMPA
AMPA
AMPA
AMPA
AMPA
AMPA
AMPA









50
100
22
80
25-75
50
50

CA1
CA1
CA1
CA1
CA1
CA3
CA3

Adult
Adult
~P30 (130-160g)
P21-40
P12-20
P21-26
P3-10

NMDA
NMDA
NMDA
NMDA
NMDA
NMDA








25-100
100
75
50
100
80-100

CA1
CA1
CA3
CA3
CA1
CA1

Adult
P4-7
P5
P5
P20-25
P21-26
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Author (year)
Lovinger et al. 1990
Lovinger et al. 1990
Randall et al. 1995
Carta et al. 2003
Hendricson et al 2003
Mameli 2005
Mameli 2005
Lovinger et al. 1990
Gordey et al. 2001
Mameli et al. 2005
Mameli et al. 2005
Swartzwelder et al. 1995
Suvarna et al 2005; Yaka 2003

Contributions of early network activity for synapse stabilization
Studies suggest that plasticity driven by correlated activity of developing
neuronal networks is an important endogenous mechanism leading to synapse
stabilization. In the hippocampus of rats and non-human primates,
neurotransmitter-mediated synaptic signaling has been shown to begin with
GABAergic transmission, followed by the acquisition of glutamatergic signaling
(Ben-Ari, 2002; Khazipov et al., 2001; Tyzio et al., 1999). Contrary to the adult
animal, GABAA receptor-mediated transmission is depolarizing during the 3rd
trimester-equivalent period of development, where immature neurons have high
[Cl-]i (Ben-Ari, 2002). This developmental effect of GABAergic transmission can
reduce the voltage-dependent Mg2+ block of NMDA receptors (NMDARs), thus
facilitating increases of postsynaptic Ca2+ (Leinekugel et al., 1997). This
depolarizing effect of GABA, however, is self-limiting preventing over excitation
via increasing conductance across the plasma membrane and shunting of
excitatory current (Ben-Ari et al., 2007). In addition, GABAA receptor-dependent
membrane potential depolarization can also lead to inactivation of Na+ channels
resulting in reduced action potential generation (Zhang and Jackson, 1995). This
depolarizing action of GABAA receptors—along with the excitatory effects of
glutamatergic transmission mediated by AMPARs and/or NMDARs—has been
shown to drive large network oscillations termed giant depolarizing potentials
(GDPs). GDPs have been found in many developing brain regions, including the
hippocampus and cortex (Ben-Ari et al., 2007; Ben-Ari, 2001). GDPs are
relatively slow recurrent waves of activity lasting several hundred milliseconds,
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which generate large Ca2+ transients. The GDPs are thought to guide the
development of synaptic connections and network formation, as suggested by a
recent study. Kasyanov and colleagues (2004) found in brain slices from P1-P6
rat pups, that if a presynaptic stimulation of mossy fiber-CA3 synaptic
connections was paired with a GDP, the result was “unsilencing” of synapses
with low probabilities of transmitter release and long-lasting potentiation and
strengthening of these connections. Furthermore, this potentiation was
dependent on a postsynaptic rise in intracellular Ca2+ (Kasyanov et al., 2004).
Thus, these results suggest that GDP-driven neuronal depolarizations facilitate,
in part, Hebbian mechanisms of increased synaptic efficacy and network
formation (Kasyanov et al., 2004).
Galindo and colleagues examined the effect of EtOH on GDPs and found
that acute application at concentrations as low as 10 mM (legal intoxication limit
~17.4 mM) reversibly increases the frequency of these events in the CA3
hippocampal region in brain slices from P3-7 rat pups (Galindo et al., 2005). This
effect was due to a positive feedback loop of interneuron-pyramidal cell firing
driven by EtOH-mediated potentiation of GABAergic transmission via an increase
in GABA release (Galindo et al., 2005). The increased GDP frequency by EtOH
also led to increased intracellular Ca2+ levels and Ca2+ transients, suggesting that
EtOH could affect Ca2+-dependent processes that are essential for synapse
stabilization, such as those discussed above (Galindo et al., 2005).

Synaptic plasticity mechanisms stabilizing synaptic connections
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In addition to network-driven activity to stabilize and “unsilence” synaptic
connections, there is a consensus that strongly correlated-activity also
strengthens and stabilizes immature synaptic connections during the thirdtrimester equivalent period and throughout life. Experimentally, high-frequency
stimulation paradigms have been shown to produce this effect. Classically, an
increase in synaptic strength of AMPAR-mediated responses after such an
induction paradigm is referred to as long-term potentiation (LTP), which has been
shown, using NMDAR antagonists and/or intracellular Ca2+ chelation, to be
dependent on NMDAR-mediated Ca2+ entry (Durand et al., 1996; Abrahamsson
et al., 2007; Liao and Malinow, 1996; Puglia and Valenzuela, In press). This
raises an interesting question: if synapses are indeed truly postsynaptically silent,
how then is the voltage-dependent Mg2+ block of NMDARs alleviated in
developing postsynaptic neurons? As previously mentioned, depolarizing
GABAergic transmission and GDP’s could be a potential mechanism (Leinekugel
et al., 1997; Kasyanov et al., 2004). Another possible solution is the expression
of NMDARs that have reduced sensitivity to Mg2+ blockade, such as those
containing the NR2D subunit (Arvanian et al., 2004; Okabe et al., 1998).
Additionally, the membrane potential at synapses may be more depolarized with
respect to the soma, leading to removal of the Mg2+ block (Williams and Mitchell,
2008). In the hippocampus, Ca2+-permeable AMPARs (i.e. GluR2-lacking)
expression have also been shown to be developmentally regulated, with
increased levels during the first 2 postnatal weeks (Zhu et al., 2000). This subset
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of AMPARs has been shown to be inserted into the immature synapse in
response to spontaneous activity and these AMPARs then get replaced in an
activity-independent manner by Ca2+-impermeable AMPARs (GluR2-containing),
likely preserving synaptic strength (Zhu et al., 2000). Similar increases in
synaptic Ca2+-permeable AMPAR expression and replacement by Ca2+impermeable AMPARs have been observed in studies of LTP in more mature
animals (Plant et al., 2006) but see (Adesnik and Nicoll, 2007). Ca2+ influx
through this subset of AMPARs may provide additional signaling, facilitating the
transition to the mature synaptic phenotype (Molnar et al., 2002; Pickard et al.,
2000).
To the best of my knowledge, there is only one study on the effects of
EtOH on synaptic plasticity mechanisms during the third-trimester equivalent
period. Acute EtOH application was shown to strengthen AMPAR-mediated
synaptic responses (Mameli and Valenzuela, 2006). This was done using a
minimal stimulation paradigm that does not evoke a post-synaptic response (or
very few responses); however, when acute EtOH (15 – 75 mM) was applied,
there was an increase in AMPAR-mediated responses and a decrease in the
failure rate of responses in the CA1 hippocampal region (Mameli and Valenzuela,
2006). This effect was developmentally regulated, and was not observed after
P5 (Mameli and Valenzuela, 2006).

Summary
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The third trimester-equivalent is a period of intense synaptic formation and
refinement that has shown acute sensitivity to EtOH. Animal models of EtOH
exposure during this period demonstrate lasting impairments in behavioral tests
of learning and memory, which probe hippocampal function (Thomas et al., 2002;
Thomas et al., 2004; Goodlett and Johnson, 1997). Several studies have
suggested that plasticity mechanisms guide synaptic formation and refinement
during this critical period of development (Medina and Krahe, 2008; Cline and
Haas, 2008; Constantine-Paton and Cline, 1998; Garaschuk et al., 2000; Voronin
and Cherubini, 2004; Nosyreva and Huber, 2005; Yasuda et al., 2008; Yasuda et
al., 2003); however, the effects of EtOH on synaptic plasticity in the hippocampus
during the third trimester-equivalent period are poorly understood.
Fundamental to synaptic plasticity is the modulation of ionotropic
glutamate receptor function. Studies of EtOH’s actions on glutamatergic
transmission during the third trimester-equivalent period have mainly focused on
the CA3 region. During the early portions of the third trimester- equivalent, EtOH
was shown to increase the frequency of GDPs in the CA3 hippocampal region
and this effect was driven by an enhancement in spontaneous GABA release at
interneuron-to-CA3 pyramidal neuron synapses (Galindo et al., 2005). In
addition, both during the early and late portions of the third trimester-equivalent
period, EtOH has been shown to inhibit glutamate release as well as AMPARmediated transmission in the CA3 hippocampal region (Mameli et al., 2005).
However, the effects of EtOH on glutamatergic synaptic transmission and
plasticity in the CA1 region have only been assessed in the study of (Mameli and
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Valenzuela, 2006), which only examined short-term modulation of AMPARmediated transmission under conditions of minimal stimulation during the early
portion of the third trimester-equivalent. The studies described in this
dissertation represent a more thorough characterization of the short- and longterm effects of EtOH on AMPAR and/or NMDAR-mediated synaptic transmission
and plasticity in the CA1 region.
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2. Goals of this study
1. Does acute EtOH exposure inhibit glutamatergic transmission and plasticity in
the CA1 hippocampal region during the late portion of the third trimesterequivalent?
Previous studies have shown that acute EtOH application inhibits
glutamate release as well as AMPAR-mediated (but not NMDAR-mediated)
transmission in the CA3 hippocampal region during the late portion (i.e. P7-9) of
the third trimester-equivalent period (Mameli et al., 2005). However, NMDARand AMPAR-mediated responses in pyramidal cells in layers 2/3 of the cortex
were insensitive to acute EtOH application in brain slices from P7-9 rat pups,
indicating region specific differences of EtOH sensitivity (Sanderson et al., 2009).
Therefore, we examined the effect of acute EtOH exposure on NMDAR- and
AMPAR-mediated responses and glutamate release in the CA1 hippocampal
region. Since synaptic plasticity mechanisms are critical for synapse maturation,
we further investigated the acute effect of EtOH exposure on LTP in this
hippocampal region. These studies systematically explored the effect of EtOH
on glutamatergic signaling and plasticity in the CA1 hippocampal region and
provided baseline data necessary required for a better understanding of the
chronic EtOH exposure studies described below.

2. Does chronic EtOH exposure impair glutamatergic transmission and plasticity
in the CA1 hippocampal region during the late portion of the third trimesterequivalent?
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Although fundamental, studies of acute EtOH application do not represent
the gradual rise and fall of blood EtOH concentrations that occur with maternal
consumption. To more closely mimic repeated in vivo EtOH exposure during the
third trimester-equivalent period, we used a vapor inhalation paradigm
(discussed in the next section). Results from goal 1 above showed that acute
EtOH exposure inhibited both AMPAR- and NMDAR-mediated responses. Thus,
we hypothesized that repeated in vivo third trimester-equivalent EtOH exposure
would lead to a compensatory increase in NMDAR and AMPAR function that
would result in increased synaptic strength and enhanced LTP during the
withdrawal period. These EtOH-induced effects could result in abnormal
synapse maturation and/or increased neuronal death in the CA1 region, leading
to long-lasting cognitive deficits.

3. Does chronic EtOH exposure affect glutamatergic transmission in the CA1
hippocampal region during the early portion of the third trimester-equivalent?
Acute EtOH exposure has been shown to strengthen AMPAR-mediated
responses in the CA1 hippocampal region during the early third trimesterequivalent period, as well as to potentiate network activity in the CA3 region,
which provides excitatory input to the CA1 region (Mameli and Valenzuela, 2006;
Galindo et al., 2005). During this early developmental period, studies have
shown that increases in neuronal activity in hippocampal slice cultures induce
synaptic insertion of Ca2+-permeable AMPARs into CA1 pyramidal neurons.
These receptors are then gradually replaced in an activity independent manner
by Ca2+-impermeable AMPARs (Zhu et al., 2000). Thus, during the early third
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trimester, when synapses are beginning to form, we tested the hypothesis that
repeated in vivo exposure to EtOH strengthens AMPAR-mediated
neurotransmission in the CA1 region via an increase in synaptic expression of
Ca2+-permeable AMPARs. Studies presented here address AMPAR-mediated
synaptic strength, functional expression of Ca2+-permeable AMPARs, and acute
EtOH effects of AMPAR-mediated responses during the early portion of the third
trimester-equivalent. Strengthening of AMPAR-mediated transmission during
this period could lead to premature stabilization of synapses and abnormal
development of hippocampal circuitry.
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3. Overview of approach
The aims of this study address the effects of EtOH during the human third
trimester-equivalent period. In rats, this period occurs during the first 10-12
postnatal days of life, and studies presented here focus on this period. The rat
model was chosen for several reasons. The majority of studies characterizing
developmental hippocampal physiology and the effects of EtOH have largely
been carried out in the rat model. In addition, rat metabolism of EtOH more
closely resembles that of the human, as opposed to the mouse model where
EtOH levels rapidly rise and fall (Livy et al., 2003b). The ease of housing and
relative cost, compared to other appropriate models such as the guinea pig, pig,
and non-human primate were additional factors for the choice of this model
system.
Electrophysiological studies were carried out using the acute brain slice
preparation. This procedure of preparing brain slices allows experimentation on
otherwise difficult or inaccessible brain regions, including the hippocampus.
Although this technique preserves some of the circuitry, inevitably some is lost
due to the slicing procedure, and this will be discussed in the limitations section.
In a subset of studies, acute EtOH was bath applied to brain slices.
Although the rapid rise of EtOH concentrations (over minutes) does not
accurately mimic in vivo EtOH pharmacokinetics, this mode of application is a
useful tool in determining the basic physiology of EtOH-mediated effects at the
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synaptic and cellular levels. In addition, these studies provide data required for
the interpretation of chronic in vivo EtOH exposure studies.
Various methods exist to model in vivo EtOH exposure during the third
trimester-equivalent in rats. Several examples are the “pup in the cup” model
where surgical implantation of an intragastric tube delivers an EtOH-containing
liquid diet, intragastric gavage, and direct injection (Berman and Hannigan, 2000;
Ikonomidou et al., 2000). The model we used was an EtOH vapor-inhalation
paradigm. Advantages of this are that the dam and pups do not need to be
separated, minimizing neonate and maternal stress. In addition, the gradual rise
and fall of EtOH levels occurs over hours, mimicking EtOH pharmacokinetics
during human consumption (Galindo and Valenzuela, 2006). Limitations exist
with all exposure paradigms and those pertinent to studies presented here will be
further addressed in the limitations section.
In all of my studies, the range of EtOH concentrations was 20-80 mM. As
a reference, the standard legal intoxication limit is 17.4 mM (0.08 g/dL). Studies
presented here represent a broad range of maternal consumption levels. If we
infer from the studies of maternal EtOH consumption that approximately 1% of
women report binge drinking during the third trimester, and this is defined as 5 or
more drinks at the same time or over a couple of hours, then approximate
maternal blood levels would be estimated to be greater than 33 mM (0.15 g/dL).
Although some studies presented here use elevated EtOH concentrations, it is
reasonable to estimate that drinking can produce these levels, particularly in
alcoholic women. Case reports have shown maternal blood EtOH concentrations
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of 57 - 65 mM (0.26 – 0.3 g/dL) at the time of birth, and 67 mM (0.31 g/dL) in the
newborn (Fischer et al., 2003; Silva et al., 1987). Thus, studies here are
modeling a range of EtOH concentrations achieved by some pregnant women
during the third trimester.
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4. Ethanol acutely inhibits ionotropic glutamate
receptor-mediated responses and long-term potentiation
in the developing CA1 hippocampus

Michael P. Puglia, and C. Fernando Valenzuela
Department of Neurosciences
University of New Mexico Health Sciences Center
Albuquerque, NM 87131

(Alcoholism Clinical and Experimental Research; in press)
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Abstract
Background- Developmental ethanol (EtOH) exposure damages the
hippocampus, causing long-lasting alterations in learning and memory.
Alterations in glutamatergic synaptic transmission and plasticity may play a role
in the mechanism of action of EtOH. This signaling is fundamental for
synaptogenesis, which occurs during the third-trimester of human pregnancy
(first 12 days of life in rats).

Methods- Acute coronal brain slices were prepared from 7-9 day-old rats.
Extracellular and patch-clamp electrophysiological recording techniques were
used to characterize the acute effects of EtOH on α-amino-3-hydroxyl-5-methyl4-isoxazole-propionate receptor (AMPAR)- and N-methyl-D-aspartate receptor
(NMDAR)-mediated responses and long-term potentiation (LTP) in the CA1
hippocampal region.

Results- EtOH (40 and 80 mM) inhibited AMPAR- and NMDAR-mediated field
excitatory postsynaptic potentials (fEPSPs). EtOH (80 mM) also reduced
AMPAR-mediated fEPSPs in presence of an inhibitor of Ca2+ permeable
AMPARs. The effect of 80 mM EtOH on NMDAR-mediated fEPSPs was
significantly greater in presence of Mg2+. EtOH (80 mM) neither affected the
paired-pulse ratio of AMPAR-mediated fEPSPs nor the presynaptic volley. The
paired-pulse ratio of AMPAR-mediated excitatory postsynaptic currents was not
affected either, and the amplitude of these currents was inhibited to a lesser
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extent than that of fEPSPs. EtOH (80 mM) inhibited LTP of AMPAR-mediated
fEPSPs.

Conclusions- Acute EtOH exposure during the third-trimester equivalent of
human pregnancy inhibits hippocampal glutamatergic transmission and LTP
induction, which could alter synapse refinement and ultimately contribute to the
pathophysiology of fetal alcohol spectrum disorder.

Keywords: Ethanol, development, plasticity, glutamate, synaptic.
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Introduction
Ethanol (EtOH) exposure during development can produce severe and
long-lasting deficits in many organs, including the brain (Sokol et al., 2003;
Warren and Foudin, 2001). Among the consequences of EtOH-induced brain
damage are behavioral disorders, mental retardation, and learning and memory
deficits (Warren and Foudin, 2001). Electrophysiological, structural, and
behavioral studies performed with human and animal subjects suggest that
learning and memory deficits are, in part, a consequence of damage to the
hippocampal formation (Berman and Hannigan, 2000; Costa et al., 2000b).
Spatial memory tests have demonstrated abnormalities in hippocampal function
in children with fetal alcohol syndrome and in animal models of this condition
(Hamilton et al., 2003; Johnson and Goodlett, 2002).

However, the

mechanisms by which EtOH exerts its deleterious effects on the hippocampal
formation are not well understood.
Studies from several laboratories suggest that the mechanism of action of
EtOH on hippocampal development involves alterations in glutamatergic synaptic
transmission (Reviewed in Berman and Hannigan, 2000; Costa et al., 2000b).
One study suggested that inhibition of NMDA receptors (NMDARs) induced by
acute EtOH administration during the human third trimester-equivalent period of
development (i.e., neonatal period in the rat) triggers widespread apoptotic
neurodegeneration in many brain regions, including the CA1 hippocampal region
(Ikonomidou et al., 2000). However, whether EtOH inhibits NMDAR function in
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CA1 neurons during this developmental period has not been tested. Studies
from our laboratory indicate that NMDARs in CA3 pyramidal neurons in acute
brain slices from neonatal rats are relatively insensitive to EtOH; in contrast,
AMPA receptor (AMPAR) function and glutamate release were unexpectedly
found to be particularly sensitive to EtOH in these neurons (Mameli et al., 2005).
In light of these findings with CA3 pyramidal neurons, we hypothesized that acute
EtOH exposure inhibits AMPAR function and glutamate release in CA1 pyramidal
neurons, without affecting NMDARs.
Since glutamatergic neurotransmission is essential for certain forms of
synaptic plasticity, a corollary of this hypothesis is that EtOH exposure should
also affect plasticity in developing hippocampal neurons, where this process is
thought to play a central role in synaptogenesis (Constantine-Paton and Cline,
1998). Many developing hippocampal Schaffer collateral-CA1 synapses are
silent at resting membrane potentials; i.e., they exhibit currents mediated by
NMDARs but not AMPARs (Kerchner and Nicoll, 2008; but see Groc et al.,
2002). It has been suggested that expression of AMPARs is limited in these
immature structures (Fiala et al., 1998; Matsuzaki et al., 2001). Recent evidence
indicates that basal activation of NMDARs inhibits AMPAR-mediated responses
during the synaptic maturation period (Adesnik et al., 2008; Hall et al., 2007).
When NMDARs are activated by strong synchronous activity, they stimulate
AMPAR recruitment to the postsynaptic density, contributing to synapse
formation (Constantine-Paton and Cline, 1998; Leinekugel, 2003; Citri and
Malenka, 2008; Durand et al., 1996; Maletic-Savatic et al., 1999; but see Zito et
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al., 2009). Excessive spontaneous excitatory activity in cultured cortical neurons
was shown to cause premature synaptic stabilization via AMPAR insertion into
silent synapses and it was postulated that this could limit the range of
connections in the neuronal network (Voigt et al., 2005). Chronic NMDAR
blockade during early development in hippocampal organotypic slice cultures
demonstrated a decreased threshold for LTP induction and a shift in baseline
synaptic efficacy (Savic et al., 2003). Collectively, these studies suggest that if
EtOH produced alterations in activity-dependent synaptic plasticity mechanisms,
these could have a negative impact on the maturation of developing neuronal
networks.
In this study, we used acute brain slices from postnatal day (P) 7-9 rats
and electrophysiological techniques to characterize the acute effects of EtOH on
AMPAR- and NMDAR-mediated responses in the CA1 region. We then
investigated whether EtOH had any presynaptic effects by measuring the pairedpulse ratios of AMPAR-mediated responses and the presynaptic volley. Lastly,
we tested the effects of acute EtOH on LTP induced via high-frequency tetanic
stimulation.
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Experimental Procedures
Tissue preparation and solutions
EtOH (99.8%) molecular biology grade from Sigma (cat #E7023) was
used. Unless indicated, all other chemicals were from Sigma (St. Louis, MO) or
Tocris Cookson (Bristol, UK). Timed-pregnant Sprague-Dawley rats were
provided by Harlan (Indianapolis, IN). Both male and female rat pups (postnatal
day (P) 7-9) were anesthetized with 250 mg/kg ketamine and coronal brain slices
(300 μm) were prepared using a vibratome, as previously described (Mameli et
al., 2005). After a recovery period of 45 min at 35-36 ºC, slices were stored in
artificial cerebrospinal fluid (ACSF) for 1-8 hr at room temperature. ACSF
contained the following (in mM): 126 NaCl, 2 KCl, 1.25 NaH2PO4, 1 MgSO4, 26
NaHCO3, 2 CaCl2, 10 glucose, and 0.01 gabazine (also known as SR-95531)
equilibrated with 95% O2/5% CO2. When indicated, the ACSF contained no
MgSO4 and 3 mM CaCl2 (or 0.5 mM MgSO4 and 2.5 mM CaCl2), 50 µM DL-2amino-5-phosphonovaleric acid (AP5), 10 µM 2,3-dioxo-6-nitro-1,2,3,4tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX), 100 µM 1-naphthylacetyl
spermine trihydrochloride (NASPM), 50 µM GYKI-53655, 0.5 µM tetrodotoxin
(TTX; Calbiochem, La Jolla, CA) and/or EtOH (20, 40, or 80 mM). Unless
indicated, EtOH was bath-applied for 10 min. Animal procedures were approved
by the Institutional Animal Care and Use Committee of the University of New
Mexico Health Sciences Center and conformed to National Institutes of Health
guidelines.
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Electrophysiological recordings
Recordings using an Axopatch 200B amplifier (Molecular Devices,
Sunnyvale, CA) were performed in the CA1 stratum radiatum at 32 ºC perfused
at 2 ml/min. Recording micropipette glass electrodes had resistances of 2-5 MΩ
and were filled with ACSF. AMPAR and NMDAR-mediated fEPSPs were evoked
using a concentric bipolar electrode (inner pole 25 µm; outer pole 125 µm;
Frederick Haer Company, Bowdoinham, ME) placed in the vicinity of the Schaffer
collateral fibers, approximately 200 µm from the recording electrode. Inputoutput curves were measured at the start of all recordings, and the stimulation
intensity was set to produce 40-50% of maximal responses for subsequent
experiments. Stimulus duration was 75 µs and stimuli were delivered at 0.033
Hz. For paired-pulse studies, the interpulse interval was 50 ms. LTP was
induced via tetanic stimulation (100 Hz train for 1 s; this train was repeated a
total of 3 times at 5 s intervals).
Whole-cell patch-clamp recordings were performed as previously
described (Mameli et al. 2005). Recording micropipette glass electrodes had
resistances of 4-7 MΩ, and were filled with an internal solution containing (in
mM): 95 K-gluconate, 40 KCl, 10 HEPES, 2 MgCl2, 3 Na2ATP, 0.4 NaGTP, and 5
QX-314. The pH was 7.2 and the osmolarity was 270 mOsm. Access
resistances were between 20-30 MΩ, and recordings were discarded if the
access resistance changed more than 20%. The membrane potential was
clamped at -65 mV (the liquid junction potential was 11.3; therefore, the
corrected voltage was -76.3 mV). For evoked excitatory postsynaptic current
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recordings (eEPSCs), stimulus duration, intensity, and frequency were the same
as for fEPSP recordings. For perforated-patch recordings, we used the same
internal solution (without QX-314) containing amphotericin-B (5-10 µg/ml). A
stock solution of amphotericin-B (1 mg/mL in dimethylsulfoxide) was prepared
every day, sonicated for 10-20 min and maintained under constant vortexing.
Amphotericin-B from this stock solution was freshly added to aliquots of internal
solution every 1-2 hours. The tips of the glass electrodes were pre-filled with
amphotericin-B-free ACSF, and then filled with the amphotericin-B-containing
internal solution. A 1-10 GΩ seal was obtained, then the voltage was clamped at
-65 mV (the liquid junction potential corrected voltage was -76.3 mV), and the
access resistance was monitored for perforation. When access resistances were
between 60-80 MΩ, recordings were started and these were discarded if there
were sudden changes in access resistance, indicating conversion to the wholecell configuration. The ACSF contained 10 µM gabazine and 50 µM AP5 for
whole-cell and perforated-patch recordings.

Data Analysis
Data were acquired and analyzed with pClamp 9 (Molecular Devices) and
GraphPad Prizm 4.0 (San Diego, CA). The short time interval between the
presynaptic volley and fEPSP prevented accurate measurement of the slope in
some experiments. Therefore, fEPSP amplitude and area were measured.
Recordings with greater inter-electrode separation distance (~400 μm) were
attempted to eliminate volley contamination of the fEPSP; however, the
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amplitude of the fEPSP was substantially reduced, making it difficult to assess
the inhibitory effect of EtOH. For each experiment, baseline and washout were
defined as the average of 10-20 fEPSPs recorded immediately before EtOH
application and the last 5-10 min of washout, respectively. For experimental
conditions, 10 fEPSPs immediately preceding the start of the washout or further
experimental procedures were averaged for analysis. For LTP studies, the
percent change from baseline was measured after 30 min from induction and
was the average of 20 fEPSPs. Except for the plasticity studies, the effect of
acute EtOH exposure was quantified with respect to the average of baseline and
washout responses. The paired-pulse ratio was calculated as the ratio of
AMPAR-mediated fEPSP2/fEPSP1 (or eEPSC2/eEPSC1). Statistical analyses
were performed by unpaired t-test, one sample t-test vs. a theoretical mean of
zero or 100%, or one-way ANOVA followed by Bonferroni post hoc test; a p ≤
0.05 was considered to be statistically significant. Data are presented as mean ±
SEM.
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Results
Characterization of input-output relationships for AMPAR- and NMDARmediated fEPSPs
To initially characterize AMPAR- and NMDAR-mediated fEPSPs, inputoutput curves were measured. AMPAR-mediated fEPSPs were recorded in the
presence of gabazine (10 µM; GABAA receptor blocker) and AP5 (50 µM;
NMDAR blocker) with increasing stimulus intensities (Fig. 1A). NMDARmediated fEPSPs were recorded in the presence of gabazine (10 µM), NBQX (10
µM; AMPA/kainate receptor blocker) and in Mg2+-free ACSF (Fig. 1B). The
average stimulus intensities that elicited a 50% of maximal stimulation response
were 0.67 ± 0.08 mA and 0.41 ± 0.05 mA for AMPAR- and NMDAR-mediated
fEPSPs, respectively (Figs. 1C-D). GYKI-53655 (50 µM) blocked AMPAR
fEPSPs leaving only the presynaptic volley spike (n=4; 1E), confirming that these
were mediated by AMPARs. The non-NMDA antagonist, NBQX (10 µM)
produced a similar inhibitory effect (n=6; data not shown). NMDAR-mediated
fEPSP responses were inhibited by 50 µM AP5 (n=8; 1F).

Acute exposure to EtOH inhibited AMPAR- and NMDAR-mediated fEPSPs
To address the effects of acute bath application of EtOH on ionotropic
glutamatergic signaling, we first characterized effects on pharmacologically
isolated AMPAR-mediated responses. EtOH (80 mM) reversibly inhibited
AMPAR-mediated fEPSPs (Fig. 2A). On average, inhibition was 15.88 ± 1.04%
(n= 6; p<0.01 by one-sample t-test vs. zero; Fig 2B and 5A). To determine if
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Mg2+ concentration affects EtOH mediated inhibition, AMPAR-mediated fEPSPs
were recorded in the absence of Mg2+. EtOH (80 mM) reduced AMPARmediated fEPSP amplitude by 9.76 ± 3.60% (n= 6; p<0.05 by one-sample t-test
vs. zero; Fig. 5A), and this was not different from the inhibition observed in the
presence of Mg2+ (not significant (N.S.) by one-way ANOVA followed by
Bonferroni post hoc test). We further tested the effects of EtOH (80 mM) in adult
rats (P 40) and found that it did not significantly affect AMPAR-mediated fEPSP
amplitude or area (n=5; N.S. by one-sample t-test vs. zero; p<0.01 by Bonferroni
post hoc test vs P7-9; Fig. 5A and Table 1).
To determine if Ca2+ influx through Ca2+-permeable AMPARs alters EtOH
sensitivity, we blocked these receptors with the synthetic polyamine NASPM (100
µM) and tested the effects of EtOH on the remaining responses (i.e. mediated by
Ca2+ impermeable AMPARs).

NASPM inhibited the fEPSP amplitude by 18.46

± 2.85% (n=11; p<0.01 by one-sample t-test vs. zero; Fig. 3). In presence of
NASPM, EtOH rapidly and reversibly inhibited fEPSP amplitude by 19.32 ±
1.66% (n=11; p<0.01 by one-sample t-test vs. zero; Fig. 3 and 5A).
NMDAR-mediated fEPSPs were recorded in Mg2+-free ACSF, as
described above. Acute EtOH (80 mM) application reversibly inhibited NMDARmediated fEPSPs (Fig. 4A). The percent inhibition from the average of baseline
and washout was 16.81 ± 2.91% (n=9; p<0.01 by one sample t-test vs. zero; Fig.
4C and 5B). Because Mg2+ has been shown to modulate NMDAR sensitivity to
EtOH, we measured its effect on NMDAR-mediated fEPSPs in ACSF containing
0.5 mM Mg2+ and 2.5 mM Ca2+ (Fig. 4B) Under these conditions, we found that
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80 mM EtOH inhibited the NMDAR-mediated fEPSPs by 29.18 ± 3.16% (n=7;
p<0.01 by one-sample t-test vs. zero; Fig. 4D and 5B). This effect was
significantly larger when compared to NMDAR-mediated fEPSPs recorded in
Mg2+-free ACSF (p<0.05 by one-way ANOVA followed by Bonferroni post hoc
test; Fig. 5B).
Fig. 5 summarizes these effects of 80 mM EtOH on fEPSP amplitude, and
also shows the effects of lower EtOH concentrations. Small but significant
effects on AMPAR- and NMDAR-mediated fEPSP amplitudes were detected with
40 mM EtOH; however, no significant effects were observed with 20 mM EtOH.
Dose dependent effects of EtOH revealed significant differences between 80 mM
vs. 20 mM and 40 mM EtOH for both AMPAR- and NMDAR-mediated fEPSPs
(p<0.05; by one-way ANOVA followed by Bonferroni post hoc test).
Table 1 summarizes the effects of EtOH on field, whole-cell and
perforated patch fEPSP or eEPSC recordings analyzed for event area. In
virtually all cases, these results were similar to those obtained with amplitude
analysis, with the exception that NMDAR-mediated fEPSP area was significantly
inhibited by 20 mM EtOH (n=4; p<0.05 by one-sample t-test vs. zero) but not by
40 mM EtOH exposure (n=5; N.S. by one-sample t-test vs. zero; Table 1) in
ACSF lacking Mg2+.

Acute EtOH does not affect glutamate release or the presynaptic volley
To assess the effects of EtOH on glutamate release, paired-pulse
plasticity of AMPAR-mediated fEPSPs was assessed (Fig. 6). Recordings were
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performed in the presence of gabazine (10 µM) and AP5 (50 µM).

The percent

change in the paired-pulse ratio of control recordings (-2.9 ± 11.6%; relative to
the average of the baseline and washout periods in the same slice) was not
significantly different from the percent change in the paired-pulse ratio (4.33 ±
1.71%) recordings obtained in presence of 80 mM EtOH (n=7-10; N.S. by
unpaired t-test). Paired-pulse ratios of AMPAR-mediated eEPSCs were also
recorded under whole-cell patch-clamp and perforated-patch conditions. EtOH
(80 mM) did not significantly affect the paired-pulse ratios of AMPAR-mediated
eEPSCs (whole cell = 0.1 ± 5.2 % data not shown; perforated-patch = -3.28 ±
2.3%; Fig 6E; N.S. by one sample t-test v. zero; n=4 for each configuration).
In the whole-cell configuration, 80 mM EtOH did not significantly inhibit
eEPSC1 amplitude (-11.97 ± 7.90% from the average of baseline and washout
by one sample t-test v. zero; n=4, data not shown). In the perforated-patch
configuration, 80 mM EtOH had a small but significant inhibitory effect on
eEPSC1 amplitude (-4.84 ± 1.3% from the average of baseline and washout by
one sample t-test v. zero; n=4, Fig. 6D-E) and area (Table 1). The percent
inhibition of eEPSC1 amplitude (but not area) was significantly smaller than that
observed in the AMPAR-mediated fEPSP recordings (p<0.01 by unpaired t-test).
In perforated-patch experiments, EtOH did not significantly affect the holding
current (4.96 ± 6.45% of control), membrane time constant (13.2 ± 8.57% of
control) and membrane resistance (4.9 ± 2.95% of control) from the average of
baseline and washout (n=4; N.S. by one sample t-test v. zero; membrane time
constant and membrane resistance were measured from responses to a 10 mV
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hyperpolarizing step of 10 ms duration). Similar results were found for the
holding current (6.7 ± 8.9 % of control), membrane time constant (13.57 ± 6.69%
of control) and membrane resistance (4.38 ± 2.36% of control) in whole-cell
recordings (n=4; N.S. by one sample t-test v. zero).
To assess the effect of EtOH on presynaptic excitability, measurements of
the presynaptic volley were performed (Fig. 7). Recordings were performed in
the presence of gabazine (10 µM), NBQX (10 µM), and AP5 (50 µM). EtOH (80
mM) did not significantly affect the presynaptic volley (21.9 ± 10.10%; n=7; N.S.
by one-sample t-test vs. zero). As expected, the presynaptic volley was blocked
by the Na+ channel antagonist, TTX (0.5 μM). After TTX application, a residual
stimulus artifact could be observed, which was subtracted to obtain the isolated
presynaptic volley response.

EtOH acutely inhibited LTP induction
To determine the effect of acute EtOH exposure on the induction of LTP, a
high-frequency stimulation protocol was used. Experiments were performed in
the presence of gabazine (10 µM) in standard ACSF. LTP induction was blocked
by AP5 (50 µM) plus MK-801 (50 µM), demonstrating that it was NMDARdependent (10.2 ± 14.92% change in fEPSP amplitude; n=9; N.S. by one-sample
t-test vs. zero; data not shown). In the absence of EtOH, high-frequency
stimulation increased the amplitude of the AMPAR-mediated fEPSP by 25.3 ±
7.33% from baseline (n=6; p<0.05; by one-sample t-test vs. zero; Fig. 8A). For
EtOH studies, the LTP induction protocol was delivered in the middle of a 10 min
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EtOH application. EtOH 40 mM (Fig. 8B) did not significantly inhibit the induction
of LTP; the fEPSP amplitude increase in the presence of EtOH (40 mM) was
22.5 ± 4.18% (p<0.01; n=7 by one-sample t-test vs. zero). The LTP induction
protocol was repeated in the same slice in the absence of EtOH, and it induced
an increase of 29.7 ± 8.11% from baseline, which was not significantly different
than the increase in the presence of 40 mM EtOH (N.S. by paired t-test).
For 80 mM EtOH (Fig. 8C), the percent change in AMPAR-mediated
fEPSP amplitude was 6.0 ± 5.39% (n=8; N.S. by one-sample t-test vs. zero); the
LTP induction protocol was then repeated in the same slice in the absence of
EtOH, resulting in a 24.8 ± 8.43% increase in the amplitude of the fEPSP from
baseline (p<0.05 by one-sample t-test vs. zero).
We also measured the effect of longer exposure to 80 mM EtOH on LTP.
A stable baseline of AMPAR-mediated fEPSPs was recorded and EtOH was
bath–applied (Fig. 8D), causing a 14.01 ± 3.94% reduction (at t = 13-15 min) in
the fEPSP amplitude (n=6; p<0.05 by one sample t-test from baseline). This
effect was followed by gradual run-down of the responses, which was observed
independently of whether or not high-frequency stimulation was delivered (Fig.
8D). High-frequency stimulation failed to potentiate the fEPSP under these
conditions (Fig. 8D).
Table 1 summarizes the effects of EtOH on LTP of fEPSP area. In all
cases, the effects of EtOH were similar to its effects on fEPSP amplitude.
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Discussion
To the best of our knowledge, this is the first characterization of the acute
effects of EtOH on glutamatergic transmission and plasticity in the rat CA1
hippocampal region during the third trimester-equivalent period of development.
Two effects of EtOH were demonstrated: 1) inhibition of both AMPAR- and
NMDAR-mediated responses and 2) inhibition of NMDAR-dependent LTP.
These findings add to growing evidence indicating that alterations in excitatory
amino acid-mediated neurotransmission play a role in the pathophysiology of
fetal alcohol spectrum disorder (Berman and Hannigan, 2000; Costa et al.,
2000b; Kimura et al., 2000; Olney, 2004; Thomas and Riley, 1998; Valenzuela et
al., 2007).

Acute EtOH exposure inhibits AMPAR-mediated fEPSPs
Acute inhibitory effects of EtOH have been observed on AMPAR-mediated
responses evoked by exogenous agonist application in developing and mature
neurons in different brain regions (Carta, et al, 2003; Costa, et al, 2000; Hsiao,
and Frye, 2003; Lovinger, et al, 1989; Lu, and Yeh, 1999; Martin, et al, 1995;
Moykkynen, et al, 2003; Nie, et al, 1994; Valenzuela, et al, 1998). EtOH has also
been shown to acutely inhibit the function of non-NMDA glutamate receptors in
central amygdala synapses from adult rats (Zhu et al., 2007; Roberto et al.,
2004). In contrast to these studies, AMPAR function has been shown to be
relatively insensitive to acute EtOH exposure in CA3 pyramidal and dentate
granule neurons from juvenile or adult rats (Weiner et al., 1999; Ariwodola et al.,
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2003). Similar findings have been obtained in the CA1 hippocampal subfield,
where Lovinger et al. (1990) were the first to study the effect of EtOH on synaptic
AMPAR function using the acute slice preparation; these investigators reported
that 50 mM EtOH exposure did not significantly affect non-NMDAR-mediated
fEPSPs and that 100 mM EtOH reduced the amplitude of these events by only
~10%. Similarly, Randall et al. (1995) found that non-NMDAR-mediated synaptic
responses were not affected by 22 mM EtOH at Schaffer collateral-to-CA1
synapses from 130-160 g rats, and Carta et al. (2003) demonstrated that 80 mM
EtOH did not inhibit AMPAR-mediated EPSCs in CA1 pyramidal neurons from
P21-40 rats. Durand et al. (1981) also demonstrated that EtOH (100 mM) had
little effect on the amplitude of fEPSPs that were, in part, mediated by AMPARs
in the CA1 hippocampal region of adult rats. A 30 min application of 100 mM
EtOH inhibited non-NMDAR-mediated fEPSPs by ~20% in the CA1 hippocampus
of C56Bl/6 mice (Gordey et al., 2001).

In addition, EtOH (25-75 mM) did not

affect the amplitude of AMPAR-mediated miniature EPSCs in CA1 pyramidal
neurons of the rat hippocampus from P12-20 rats (Hendricson et al., 2003).
In contrast to the findings of the studies described above, we found that
acute EtOH exposure inhibits non-NMDAR-mediated fEPSPs in the CA1 region
of neonatal (but not adult) rats, where EtOH had a small but significant effect at a
concentration as low as 40 mM. Under our recording conditions, non-NMDARmediated fEPSPs were abolished by the selective AMPAR antagonist, GYKI53655, indicating that kainate receptors do not contribute to the generation of
these events. It should be noted, however, that the effects of EtOH on AMPAR
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function were either undetectable or less robust under somatic voltage-clamp
conditions. In the whole-cell configuration, 80 mM EtOH had no significant effect
on eEPSC amplitude, and, in the perforated-patch configuration, it had a smaller
action than in dendritic field recordings. These findings suggest that: 1)
intracellular signal transduction pathways that are disrupted during whole-cell
recording are required for EtOH’s action, 2) EtOH may preferentially act on
dendritic AMPARs that are not sampled under somatic patch-clamp recordings
(Williams, and Mitchell, 2008), and/or 3) EtOH may affect non-AMPAR-mediated
components of the fEPSP–for instance, those mediated by leak channels or
capacitive currents. This possibility is unlikely given that EtOH did not affect the
holding current, membrane time constant, or membrane resistance.
Previous studies have suggested that AMPAR subunit composition and
postsynaptic proteins involved in AMPAR function are developmentally regulated
in the hippocampus (CA1), which may explain the increased EtOH sensitivity of
AMPARs at P7-9 (Elias et al., 2008; Zhu et al., 2000; Fukaya et al., 2006;
Rouach et al., 2005; Morimoto-Tomita et al., 2009; Sager et al., 2009). In
addition, other factors, such as neurosteroids, play a role in the effects of EtOH in
developing CA1 pyramidal neurons. Studies from our laboratory previously
showed that EtOH strengthens AMPAR-mediated synaptic transmission in CA1
pyramidal neurons from P3-4 (but not P6-10 rats) under conditions of minimal
stimulation; this effect was mediated by an endogenous pregnenolone sulfatelike neurosteroid that acts at the presynaptic level (Mameli et al., 2005; Mameli
and Valenzuela, 2006; reviewed in Valenzuela et al., 2007). Thus, EtOH can
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either potentiate or inhibit CA1 AMPAR-mediated synaptic transmission during
the early or late portions of the third trimester-equivalent period of rat
development. We previously detected relatively potent inhibitory effects of EtOH
on AMPAR-mediated synaptic transmission in CA3 pyramidal neurons of the
developing hippocampus (Mameli et al., 2005), suggesting that immature CA1
and CA3 AMPARs may share some of the properties that confer EtOH sensitivity
and this should be explored in the future. However, synaptic AMPARs are not
sensitive to EtOH in all developing brain regions and under all experimental
conditions, as shown by the voltage-clamp studies presented here and our
recently reported results with neocortical layer II and III pyramidal neurons from
P7-9 rats (Sanderson et al., 2009).

Ca2+ influx through AMPARs is not required for modulation by EtOH
A previous study with recombinant AMPARs expressed in Xenopus
oocytes found that EtOH inhibited Ca2+-permeable (i.e. containing GluR1 +
GluR3 subunits) and Ca2+-impermeable (containing GluR2 + GluR3 subunits)
receptors to a similar extent. However, for GluR1 + GluR3 receptors, greater
EtOH inhibition was observed when the only permeant ion was Ca2+ (DildyMayfield and Harris, 1995). These findings suggest that increased intracellular
Ca2+ levels modulate AMPAR sensitivity to EtOH. Consequently, we tested the
effect of EtOH on synaptic AMPARs in the presence of an antagonist of Ca2+permeable AMPARs. The functional expression ratio of Ca2+-permeable to impermeable AMPARs was approximately 1/5, consistent with a previous report
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(Pickard et al., 2000). In the presence of NASPM, an inhibitor of Ca2+-permeable
AMPARs, EtOH reduced the fEPSP amplitude to a similar extent to controls.
These results suggest that EtOH does not preferentially inhibit Ca2+-permeable
AMPARs in developing CA1 hippocampal synapses, and Ca2+ influx through
Ca2+ -permeable AMPARs does not affect the sensitivity to EtOH. However, we
were unable to directly test the effects of EtOH on Ca2+-permeable AMPARs due
to the lack of availability of pharmacological agents to isolate these receptors.
Studies using molecular biological approaches and/or genetically modified mice
could be used to further address this issue.

Acute EtOH exposure inhibits NMDAR-mediated fEPSPs
We found that acute EtOH inhibits NMDAR-mediated fEPSPs in the CA1
region of neonatal rats; small but significant effects were detected at EtOH
concentrations of 40 mM (~5%) and 80 mM (~15%). Our findings are in general
agreement with those of Gordey et al. (2001) who showed that 100 mM EtOH
inhibits NMDAR-mediated fEPSPs by ~20% in the CA1 region of slices from P4-7
C56Bl/6 mice. Other slice electrophysiological studies performed in our
laboratory have investigated the modulation of NMDARs by EtOH in pyramidal
neurons from another hippocampal subfield; i.e., the CA3 region. In CA3
pyramidal neurons from P5 rats, currents evoked by exogenous application of
NMDA were significantly inhibited (~10%) by 75 mM EtOH, but were unaffected
by lower EtOH concentrations (Mameli et al., 2005). In slices from older rats (P910), 50 mM EtOH significantly inhibited (~8%) exogenous NMDA-evoked
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currents in these neurons (Mameli et al., 2005). Although these results are in
general agreement with the findings of the present study, it must be kept in mind
that currents evoked by exogenous NMDA are likely mediated by synaptic and
extrasynaptic NMDARs. We examined the effect of EtOH on NMDAR currents
triggered by synaptic glutamate release in CA3 pyramidal neurons and found that
these are inhibited (up to 40%) by 50 mM EtOH in slices from P3-10 rats;
however, this effect is likely a consequence of an EtOH-induced decrease of
glutamate release as discussed in more detail below (Mameli et al., 2005). In the
present study, we did not detect an effect of EtOH on glutamate release in the
CA1 region, but did find an effect on NMDAR-mediated fEPSPs. These findings
indicate that the mechanism by which EtOH modulates NMDARs in the neonatal
hippocampus is regionally specific; i.e., it predominantly inhibits NMDARmediated responses in the CA1 and CA3 region via postsynaptic and presynaptic
mechanisms, respectively.
The magnitude of inhibition of synaptic NMDAR-mediated responses in
neonatal CA1 pyramidal neurons reported here is slightly lower than that
observed in some studies with acute slices from juvenile or adult animals. For
instance, Lovinger et al. (1990) demonstrated that 25-100 mM EtOH inhibits
NMDAR-mediated fEPSPs by ~20-50% in slices from adult rats. Swartzwelder et
al. (1995) reported that CA1 NMDAR-mediated fEPSPs were inhibited by ~30%
and 40% in P20-25 rat slices acutely exposed to 30 and 100 mM EtOH,
respectively. Similarly, 80-100 mM EtOH was shown to inhibit CA1 NMDARmediated fEPSPs by ~50% in slices from P21-26 C57BL/6J mice (Suvarna et al.,
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2005; Yaka et al., 2003) and by ~20-30% in slices from adult +/fynZ mice
(Miyakawa et al., 1997). The relative insensitivity to EtOH of NMDARs in
neonatal CA1 pyramidal neurons could be attributed to expression of NR2Dcontaining NMDARs, which have been shown be less sensitive to EtOH inhibition
(Chu et al., 1995). However, NMDARs containing the NR2D subunit may not be
present in the CA1 hippocampus from rats older than P6 (Mameli et al., 2005).
Therefore, differences in the subunit composition, phosphorylation state or
association with other proteins between NMDARs in neurons from neonatal vs.
more mature animals could be responsible for age-dependent differences in
EtOH sensitivity in the CA1 region (Elias et al., 2008; Yasuda et al., 2003).
Another reason could be related to Mg2+ concentration in the ACSF. Morrisett et
al. (1991) reported that EtOH inhibits NMDAR-mediated fEPSPs in slices from
adult rats with an EC50 of ~50 mM in the presence of 1 mM Mg2+ and an EC50 of
100 mM in its absence. Jin et al. (2008) also observed enhanced inhibition of
recombinant NMDARs in the presence of Mg2+. In agreement with these
findings, we found that 80 mM EtOH had a significantly greater inhibitory effect
on NMDAR-mediated fEPSPs when recorded in the presence of 0.5 mM Mg2+
than under 0 mM Mg2+ conditions.

Lack of Presynaptic Effects of EtOH
We show here that EtOH acutely reduces the amplitude of both AMPARand NMDAR-mediated fEPSPs in neonatal CA1 pyramidal neurons. However, it
did not affect the paired-pulse ratio of AMPAR-mediated fEPSPs or eEPSCs
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under whole-cell patch-clamp and perforated-patch clamp conditions. Since
alterations in paired-pulse plasticity are an indicator of changes in transmitter
release (Zucker and Regehr, 2002), these findings suggests that EtOH does not
affect glutamate release at Schaffer collateral-to-CA1 pyramidal neuron
synapses from P7-9 rats. As mentioned above, EtOH induced a neurosteroiddependent increase in glutamate release at these synapses in slices from
younger rats (P3-4) (Mameli et al., 2005; Mameli and Valenzuela, 2006;
Reviewed in Valenzuela et al., 2007). Therefore, acute EtOH exposure exerts
developmentally-regulated actions on glutamate release in this hippocampal
region. A similar observation was made in the CA3 hippocampal region where
EtOH acutely inhibits glutamate release in slices from rats younger than P10; this
effect is mediated by inhibition of presynaptic N-type Ca2+ channels (Mameli et
al., 2005). Previous studies have shown that EtOH affects glutamate release in
several brain regions, including the CA1 hippocampal region from more mature
rats (reviewed in Siggins et al., 2005). In cultured hippocampal CA1 neurons,
EtOH decreased mEPSC frequency without affecting amplitude, suggesting that
it inhibits glutamate release; this effect was shown to be mediated by
endocannabinoid release triggered by an elevation in postsynaptic Ca2+ levels
(Basavarajappa et al., 2008). EtOH inhibited KCl-induced vesicular FM1-43
destaining in the CA1 stratum radiatum of P21-28 rats, and this effect was
occluded by antagonists of N-type and P/Q-type Ca2+ channels; EtOH also
reduced frequency of AMPAR-mediated mEPSCs in the presence, but not in the
absence of KCl (Maldve et al., 2004).

Moreover, EtOH decreased both the
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frequency of asynchronous NMDAR-mediated mEPSCs and the paired-pulse
ratio of NMDAR-mediated EPSCs in CA1 pyramidal neurons (Hendricson et al.,
2004). Future experiments should determine whether the lack of a presynaptic
effect of EtOH in the neonatal CA1 region is, in part, a consequence of a unique
pattern of voltage-gated Ca2+ channel expression in glutamatergic axonal
terminals.

Acute EtOH Exposure Inhibits NMDAR-dependent LTP
We found that the induction of LTP was suppressed by application of 80
mM EtOH. This was not observed at a concentration of 40 mM. These findings
are in agreement with the literature and indicate that exposure to relatively high
EtOH concentrations is required to inhibit LTP in the CA1 hippocampal region
(Izumi et al., 2007; Schummers et al., 1997; Sinclair and Lo, 1986; Sugiura et al.,
1995; Tokuda et al., 2007; Zhang and Morrisett, 1993; Zhang et al., 2005). One
paper showed that LTP was virtually abolished by 60 mM EtOH in slices from
P15-25 rats, but not P70-100 rats (Swartzwelder et al., 1995). However, other
studies have reported more potent effects of EtOH on LTP in the rat CA1
hippocampal region than those reported here. This could be a consequence of
differences in experimental conditions (i.e., slice preparation protocol, recording
temperature, LTP induction paradigm, and age of rats) (Randall et al., 1995;
Blitzer et al., 1990; Pyapali et al., 1999; Fujii et al., 2008). For instance, in some
but not all cases, LTP was induced by theta burst stimulation, and in other
studies there were variances in the number of pulses in the LTP induction train
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(Pyapali et al., 1999; Fujii et al., 2008). Future studies should address the effect
of EtOH on neonatal LTP evoked by different patterns of stimulation.
The mechanism by which EtOH blocks LTP in the developing CA1
hippocampus may involve inhibition of NMDARs (Blitzer et al., 1990) because the
dose-dependency of EtOH’s effect on NMDAR-mediated fEPSPs matches that of
its effect on LTP. Since our studies were performed in presence of gabazine, we
did not investigate the contribution of an EtOH-induced increase in GABAA
receptor-mediated transmission. However, future studies should examine a
potential participation of GABAA receptors in the mechanism of action of EtOH.
Studies suggest that EtOH could indirectly inhibit NMDAR-mediated responses
and LTP by increasing GABAergic transmission (Schummers et al., 1997;
Schummers and Browning, 2001). GABAergic neurosteroids were recently
shown to mediate the effects of EtOH on LTP (Izumi et al., 2007). During the
third-trimester equivalent, GABAA receptors will likely have a dual excitatory and
inhibitory action and may actually facilitate LTP induction under some conditions
(Caillard et al., 1999). In addition, the inhibitory actions of EtOH on LTP were
occluded by an angiotensin 1 receptor blocker, and this receptor may also be
involved in the mechanism by which EtOH affects LTP during the neonatal period
of rat development (Wayner et al., 1993). Inhibition of AMPARs could also
contribute to LTP blockade because these receptors are needed for removal of
Mg2+ block from NMDARs (reviewed in Kerchner and Nicoll, 2008). LTP during
this neonatal period is not dependent on CaMKII as in more mature animals, but
requires protein kinase A (Yasuda et al., 2003). EtOH may also interfere with
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these pathways uniquely involved in developmental LTP (Newton and Messing,
2006).
A limitation of our study is that the EtOH concentration increased in the
recording chamber over a short period of time (2-3 min). Human consumption of
alcoholic beverages does not cause such a sudden increase in brain EtOH
levels, even during binge drinking. Tokuda et al., (2007) showed that a gradual
increase in EtOH concentration induces the emergence of an NMDAR- and Ca2+
channel-independent form of synaptic plasticity that depends on Ca2+ release
from internal stores. Future studies should examine if EtOH produces a similar
effect in developing neurons. Moreover, to further assess the effects of gradual
increases in EtOH concentrations, the effects of EtOH exposure on
developmental LTP in vivo should also be explored in the future.

Implications of Findings
Plasticity of glutamatergic transmission may contribute to the maturation of
developing neuronal networks, for example, by stabilizing newly formed
synapses (Constantine-Paton and Cline, 1998; Leinekugel, 2003; Zhu et al.,
2000; Molnar et al., 2002). Alterations in these processes likely contribute to the
long-lasting effects of EtOH on the CA1 hippocampus of rodents exposed to
EtOH during the third trimester-equivalent of human pregnancy. For instance,
abnormal circuit formation secondary to LTP blockade in the CA1 region could
explain the deficits in input/output curves detected in this hippocampal subfield in
P45-60 rats that were exposed to EtOH vapor at P4-6 (Bellinger et al., 1999).
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EtOH inhibition of NMDAR-mediated responses could trigger apoptosis in the
hippocampal CA1 region (Ikonomidou et al., 2000), although this mechanism
may not apply to other regions such as layer II/III of neocortex or CA3 pyramidal
neurons (Mameli et al., 2005; Sanderson et al., 2009). Alternatively, EtOHinduced alterations in glutamatergic transmission could contribute to the
neurogenesis or neuronal proliferation deficits that may be responsible for
decreased pyramidal neuronal numbers in the CA1 hippocampal region of rats
exposed to EtOH during the neonatal period (Livy et al., 2003; Miller, 1995;
Martel et al., 2009). In addition, EtOH-induced NMDAR inhibition during the
neonatal period could contribute to the compensatory upregulation of these
receptors that has been detected during EtOH withdrawal (Thomas et al., 2004).
It can be concluded that therapeutic interventions that prevent the EtOH-induced
inhibition of glutamatergic transmission and plasticity in the CA1 region during
the third trimester of pregnancy could mitigate the learning and memory
alterations associated with fetal alcohol spectrum disorder.
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Figure Legends
Figure 1. AMPAR- and NMDAR-mediated fEPSP input-output curves in the CA1
hippocampus. Sample traces of (A) AMPAR- and (B) NMDAR-mediated fEPSPs
evoked at increasing stimulus intensities via stimulation of the Schaffer collateral
fibers. Events were recorded in the stratum radiatum in the presence of
gabazine (10 µM) and AP5 (50 µM) for AMPARs, and in the presence of
gabazine (10 µM), NBQX (10 µM), and absence of Mg2+ for NMDARs. Pooled
data for (C) AMPAR- and (D) NMDAR-mediated fEPSP input-output curves. (E)
AMPAR- and (F) NMDAR-mediated fEPSPs were blocked with GYKI-53655 (50
µM) and AP5 (50 µM), respectively.

Figure 2. EtOH (80 mM) inhibits AMPAR-mediated fEPSPs. (A) Sample traces
of inhibitory effects of EtOH on AMPAR-mediated fEPSP amplitudes recorded in
the presence of gabazine (10 µM) and AP5 (50 µM). (B) Time course of the
effect of EtOH.

Figure 3. EtOH sensitivity of AMPAR-mediated fEPSPs is not affected by
inhibition of Ca2+ permeable AMPARs. (A) Sample traces demonstrating the
effects of NASPM (100 µM) on AMPAR-mediated fEPSPs (10 µM gabazine and
50 µM AP5). Also shown is the EtOH (80 mM)-induced reversibly inhibition of
fEPSPs in the presence of NASPM. (B) Time course of the effect of NASPM and
EtOH.
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Figure 4. EtOH inhibits NMDAR-mediated fEPSPs. Sample traces of inhibitory
effects of 80 mM EtOH on the amplitude of NMDAR-mediated fEPSPs recorded
in the presence of gabazine (10 µM), NBQX (10µM), in Mg2+-free ACSF (A) and
0.5 mM Mg2+ ACSF (B). Time courses of the effects of EtOH in Mg2+-free ACSF
(C) and 0.5 mM Mg2+ ACSF (D).

Figure 5. EtOH dose dependently inhibits AMPAR- and NMDAR-mediated
fEPSPs. (A) The effects of 20, 40, and 80 mM EtOH are shown as percent
inhibition from the average of baseline and washout. AMPAR-mediated fEPSPs
were recorded in the presence of gabazine (10 µM) and AP5 (50 µM) in standard
ACSF. In addition, AMPAR-mediated fEPSPs were recorded in Mg2+-free ACSF.
Also illustrated is the effect of EtOH on AMPAR-mediated fEPSPs in presence of
NASPM, as well as the effect of EtOH on AMPAR-mediated fEPSPs in slices
from adult rats. (B) Effect of EtOH on NMDAR-mediated fEPSPs recorded in
Mg2+-free ACSF, and NMDAR fEPSPs recorded in 0.5 mM Mg2+ ACSF. *p<0.05,
and **p<0.01 by one-sample t-test vs. zero. See text for ANOVA results.

Figure 6. Paired-pulse ratios of AMPAR-mediated fEPSPs and eEPSCs were
not affected by acute EtOH (80 mM) exposure. Recordings were performed in
the presence of gabazine (10 µM) and AP5 (50 µM). The interpulse interval was
50 ms. (A) Sample fEPSP traces from control (i.e. no EtOH) and (B) EtOH
groups. (C) Time course of the fEPSP paired-pulse ratio for these groups. (D)
Sample traces of perforated-patch eEPSC paired-pulse recordings. (E) Summary
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of the EtOH-induced percent change of eEPSC1 amplitude and paired-pulse
ratio. *p<0.01 by one sample t-test vs. 100%.

Figure 7. Acute EtOH (80 mM) application did not affect the presynaptic volley
amplitude. Recordings were performed in the presence of gabazine (10 µM),
NBQX (10 µM), and AP5 (50 µM).

(A) Sample traces and time course (B) are

shown. Presynaptic volleys were blocked by TTX (0.5 µM). The residual signal
corresponds to a portion of the stimulus artifact.

Figure 8. Acute EtOH (80 mM, but not 40 mM) inhibited the induction of LTP in
the CA1 hippocampus of P7-9 animals. (A) LTP induction in control slices. The
LTP induction protocol (represented by the dashed lines) consisted of 3 one
second 100 Hz trains (trains were separated by 5s). Recordings were obtained
in the presence of gabazine (10 µM).
on LTP.

Effect of 40 mM (B) and 80 mM (C) EtOH

The first LTP induction protocol was delivered in the presence of

EtOH, and repeated in its absence. (D) Effects of continuous 80 mM EtOH
exposure on LTP induction; also shown are control recordings obtained from
slices in which LTP was not induced. Note different time scales in x-axis (A-D).
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4.51
2.49
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Abstract
Ethanol (EtOH) exposure during development damages the hippocampus,
causing long-lasting learning and memory deficits. Synaptic plasticity
mechanisms (e.g. long term potentiation—LTP), contribute to synapse formation
and refinement during development. We recently showed that acute EtOH
exposure inhibits glutamatergic synaptic transmission and N-methyl-D-aspartate
(NMDA) receptor-dependent LTP in the CA1 hippocampal region of postnatal
day (P) 7-9 rats. Inhibition of NMDA receptors by EtOH during development has
been postulated to induce compensatory upregulation of these receptors during
EtOH withdrawal periods, leading to excitotoxicity and hippocampal damage. We
therefore hypothesized that LTP should be enhanced with repeated in vivo EtOH
exposure, due to increased NMDA receptor function during periods of early EtOH
withdrawal. To test this hypothesis, rat pups were exposed to EtOH vapor (2 or
4.5 g/dL in air; serum EtOH concentrations = 22-32 or 70-86 mM) from P2-9 (4
hrs/day). Brain slices were prepared immediately after the end of the 4 hr
exposure on P7-9 and extracellular electrophysiological recordings were
performed 1-7 hrs later under EtOH-free conditions to model early withdrawal.
LTP was not different than group-matched controls in the 22-32 mM group;
however, it was abolished in the 70-86 mM group. Neither α-amino-3-hydroxyl-5methyl-4-isoxazole-propionate (AMPA)/NMDA receptor function nor glutamate
release was affected in the 70-86 mM EtOH exposure group. These data
suggest that repeated in vivo exposure to elevated doses of EtOH during the
third trimester-equivalent period impairs synaptic plasticity, which may alter

72

maturation of hippocampal circuits and ultimately contribute to the long-lasting
cognitive deficits associated with fetal alcohol spectrum disorder.

73

Introduction
Ethanol (EtOH) exposure during fetal development can result in a
spectrum of clinical findings (termed fetal alcohol spectrum disorder—FASD),
ranging from relatively mild central nervous system impairments, such as
learning and memory deficits, to the most severe manifestation of the disorder—
fetal alcohol syndrome (FAS). The clinical hallmarks of FAS include
characteristic facial dysmorphology, growth retardation, and impaired central
nervous system function. EtOH has been shown to affect many brain regions,
and one that has been shown to be particularly sensitive is the hippocampus
(Berman and Hannigan, 2000). Children and animals developmentally exposed
to EtOH exhibit deficits in learning and memory that are, in part, a consequence
of impaired hippocampal function (Hamilton et al., 2003; Johnson and Goodlett,
2002).
Although many mechanisms for the neuroteratogenic actions of EtOH
have been put forth, one that has received significant research efforts is impaired
glutamatergic signaling and synaptic plasticity (Berman and Hannigan, 2000;
Medina and Krahe, 2008; Medina et al., 2003; Costa et al., 2000b; Swartzwelder
et al., 1995a). During the third trimester-equivalent period (approximately
postnatal day (P) 0-10 in rats), intense glutamatergic synapse formation and
refinement occur throughout the developing brain, including the hippocampal
region, and these processes are thought to be mediated by activity-dependent
mechanisms (Durand et al., 1996; Zhu et al., 2000; Constantine-Paton and Cline,
1998; Yasuda et al., 2003; Leinekugel, 2003). The majority of studies addressing
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the effects of developmental EtOH exposure on glutamatergic signaling and
learning and memory have focused on characterizing long-lasting changes in
more mature animals. However, relatively few studies have studied the effects of
EtOH during the third trimester-equivalent period.
We have previously shown that acute EtOH exposure inhibits ionotropic
glutamate receptor-mediated responses and long term potentiation (LTP)
induction in the CA1 hippocampal region of P7-9 rat pups (Puglia and
Valenzuela, In press). We hypothesized that repeated EtOH exposure would
lead to a compensatory increase in NMDA receptor (NMDAR) and AMPA
receptor (AMPAR) function that would result in increased NMDAR synaptic
strength during the withdrawal period and, as a consequence, enhanced LTP.
This hypothesis is supported by studies in which, 6 g/Kg of EtOH was
administered on P6 in a binge-like fashion, followed 21 hrs later by MK-801 (an
NMDAR antagonist) or saline (Thomas et al., 2002). The inhibition of NMDARs
by MK-801 protected against EtOH-mediated deficits in a spatial discrimination
reversal learning task, suggesting that NMDAR-mediated upregulation during
periods of EtOH withdrawal contributes to the long-term deficits observed in FAS
and FASD (Thomas et al., 2002).
An EtOH vapor exposure paradigm was used to model human third
trimester EtOH consumption, where rat dams and pups were repeatedly exposed
to EtOH vapor from P2-9. Acute brain slices were prepared from P7-9 rat pups
and slice electrophysiological techniques were used to investigate LTP and
ionotropic glutamate receptor-mediated synaptic transmission.
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Experimental Procedures
EtOH vapor chamber exposure paradigm
Animal procedures were approved by the Institutional Animal Care and
Use Committee of the University of New Mexico Health Sciences Center and
conformed to National Institutes of Health guidelines. Timed-pregnant SpragueDawley rats (gestational days 9-17) were obtained from Harlan Laboratories Inc.
(Indianapolis, IN). Neonatal rat pups and dams were exposed to EtOH vapor as
previously described (Galindo and Valenzuela, 2006; Puglia and Valenzuela, In
press). Briefly, litters were culled to 10 pups on P2 and dams and rat pups were
exposed daily for 4 hrs per day until P9 (Fig. 1A). Exposures were started at
07:00 hrs (lights on at 06:00 hrs and lights off at 18:00 hrs). Ninety-five percent
EtOH (Cat #801VWR Tarr, Phoenix, AZ) was vaporized with a heating flask that
was regulated with a peristaltic pump. EtOH vapor mixed with air, or air alone,
was delivered to the exposure chamber for the EtOH and control groups,
respectively. Control and EtOH litters were paired based upon exposure round,
where birthdays were 0-3 days apart, and further referred to as pair-matched.
The only mortality in any of the 6 pair-matched groups was 3 pups in one litter
from the 70-86 mM EtOH exposure group.

Tissue preparation and solutions
Unless otherwise indicated, chemicals were purchased from Sigma (St.
Louis, MO) or Tocris Cookson (Ellisville, MO). Rat pups (male and female) were
deeply anesthetized with 250 mg of ketamine / Kg of body weight and euthanized
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by decapitation immediately after the 4 hr exposure to air or EtOH on P7-9.
Serum was obtained by collecting trunk blood samples, allowing them to
coagulate and centrifuging at 2.3 x g for 15 min at 4º C. Serum EtOH
concentrations (SECs) were determined using an alcohol dehydrogenase-based
assay as previously described (Puglia and Valenzuela, In press). Coronal brain
slices (400 μm) were prepared using a vibratome, as previously described
(Mameli et al., 2005). After a recovery period of 45 min at 35-36ºC, slices were
maintained for 1-7 hrs at room temperature. Artificial cerebrospinal fluid (ACSF)
contained the following (in mM): 126 NaCl, 2 KCl, 1.25 NaH2PO4, 26 NaHCO3, 1
MgSO4, 2 CaCl2, 10 glucose, and 0.01 gabazine (also known as SR-95531)
equilibrated with 95%O2/5%CO2. When indicated, the ACSF also contained 50
µM DL-2-amino-5-phosphonovaleric acid (AP5), and/or 10 µM 2,3-dioxo-6-nitro1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX) in 0 mM Mg2+ (3
mM Ca2+).

Electrophysiological recordings
Recordings were performed in the CA1 stratum radiatum with a perfusion
rate of 2 ml/min at 32ºC using an Axopatch 200B amplifier (Molecular Devices,
Sunnyvale, CA). Recording micropipette glass electrodes had resistances of 3-5
MΩ and were filled with ACSF. A concentric bipolar electrode (inner pole 25 µm;
outer pole 125 µm; Frederick Haer Company, Bowdoinham, ME) was placed in
the vicinity of the Schaffer collateral fibers, approximately 200 µm from the
recording electrode, to evoke fEPSPs. Input-output curves were measured at the
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start of all recordings, and the stimulation intensity was set at 40-50% of that
required to produce maximal responses for subsequent experiments. Stimulus
duration was 75 µs and stimuli were delivered at 0.033 Hz. LTP was induced via
tetanic stimulation (100 Hz train for 1 s; this train was repeated a total of 3 times
at 5 s intervals). For paired-pulse studies, the interpulse interval was 50 ms.

Data Analysis
Data were acquired and analyzed with the aid of pClamp 9 (Molecular
Devices) and GraphPad Prizm 4.0 Softwares (San Diego, CA). The short time
interval between the presynaptic volley and the fEPSP prevented accurate
measurement of the slope in most experiments; therefore, data were analyzed
using the fEPSP amplitude. For each experiment, baseline was defined as the
average of 20 fEPSPs immediately before drug application. For LTP
quantification, the percent change from baseline was measured after 35 min
from induction and was the average of 10 fEPSPs.
Statistical analyses of pooled data were performed using GraphPad
Prism. A p ≤ 0.05 was considered to be statistically significant. Shown data are
presented as mean ± SEM, and the number of determinations (n) represents the
number of recordings, which were performed in slices from 6-10 pups from 2-3
different litters per treatment condition.
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Results
To model EtOH exposure during the equivalent to the human third
trimester of pregnancy, rat dams and pups were exposed to air (control) or EtOH
via an inhalation paradigm (Fig 1A). Exposures occurred for 4 hrs/day and
chamber EtOH vapor levels were 2 or 4.5 g/dL (Fig. 1B), which yielded SEC’s of
27 ± 1.7 (21 - 32) and 74 ± 1.9 (70 - 86) mM, respectively (Fig. 1C). This
exposure paradigm did not affect rat pup weight gain in the 21-32 mM group;
however, in the 70-86 mM group, there was a trend towards reduced pup weights
that reached significance at P8 (Fig. 1D).
We addressed the effects of repeated in vivo EtOH exposure on LTP in
brain slices of P7-9 rat pups in the presence of gabazine (10 µM; Figs. 2-3). In
the 21-32 mM EtOH group, a high frequency LTP induction paradigm significantly
increased AMPAR-mediated fEPSP amplitude to 120.4 ± 3.7 % of baseline (at t =
50-55 min; Figs. 2A-C). Group matched controls similarly showed an increase to
113.7 ± 5.7 % in AMPAR-mediated fEPSP amplitude with respect to baseline (at
t = 50-55 min; Figs. 2A-C). The magnitude of LTP induction was not significantly
different between 21-32 mM EtOH group and group-matched controls (Fig. 2C).
In rat pups where repeated in vivo EtOH exposure led to SECs of 70-86
mM, LTP was significantly impaired, with AMPAR-mediated fEPSP amplitude
being 96.1 ± 1.8 % of baseline (at t = 50-55 min; Figs. 3A-C). Group-matched
controls showed a significant increase to 116.0 ± 5.9 % in AMPAR-mediated
fEPSP amplitude with respect to baseline (at t = 50-55 min; Figs. 3A-C). The
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magnitude of LTP induction was significantly different between the 70-86 mM
EtOH group and group-matched controls (Fig. 3C).
To investigate whether the deficits in LTP induction in the 70-86 mM EtOH
group were a consequence of alterations in ionotropic glutamatergic signaling,
NMDAR- and AMPAR-mediated input-output curves were recorded (Fig. 4).
AMPAR-mediated input-output curves were recorded in the presence of
gabazine (10 µM) and AP5 (50 µM; Fig. 4A). There were no significant
differences in the input-output curves between the EtOH and group-matched
controls (Fig. 4B). NMDAR-mediated input-output curves were recorded in the
presence of gabazine (10 µM), NBQX (10 µM) and in the absence of Mg2+ (Fig.
4C). There were no significant differences in the input-output curves between
the EtOH and group-matched controls (Fig. 4D).
Finally, we investigated whether the impaired LTP in the 70-86 mM EtOH
group was a result of alterations in glutamate release by measuring paired-pulse
plasticity of AMPAR-mediated fEPSPs (Valenzuela et al., 2007). The pairedpulse ratio is typically inversely related to the probability of glutamate release
(Mameli et al., 2005). Paired-pulse ratios were not significantly different between
the EtOH and group-matched controls (Fig 5).
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Discussion
This study was undertaken to determine if in vivo EtOH exposure during
the third trimester-equivalent period in rat pups alters glutamatergic signaling and
plasticity. The main findings of this study are that exposure to high levels of
EtOH inhibits LTP in the developing CA1 hippocampal region and that this is not
a consequence of alterations in glutamatergic synaptic efficacy or glutamate
release.
We chose an exposure paradigm that resembles repeated maternal EtOH
consumption where blood EtOH concentrations gradually rise and fall (Galindo
and Valenzuela, 2006). The EtOH vapor exposure paradigm is advantageous
because it minimizes stress in dams and neonates by eliminating the need for
maternal separation. EtOH exposure leading to SECs of 21-32 mM did not
significantly affect pup weight gain over the course of postnatal days 2-9;
however, exposure leading to SECs of 70-86 mM reduced weight gain over this
period, indicating that this paradigm effectively models FAS, where growth
retardation is a requisite for diagnosis. These results are consistent with
previous vapor-inhalation paradigms that caused growth retardation following
high EtOH exposure during the third trimester-equivalent period (Bellinger et al.,
2002). In contrast, the lower exposure dose did not affect weight, possibly
mimicking the less severe end of FASD.
Contrary to our hypothesis, LTP was impaired during the early withdrawal
period following repeated EtOH exposure. The impaired LTP was observed only
in the EtOH exposure group with SECs of 70-86 mM, suggesting that relatively
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high doses of EtOH exposure are needed to abolish synaptic plasticity
mechanisms during the third trimester-equivalent. These results are consistent
with studies of acute EtOH application in brain slices from P7-9 rat pups, where
80 mM application (but not 20 or 40 mM application) inhibited the induction of
LTP (Puglia and Valenzuela, In press). In addition, acute EtOH (60 mM)
application inhibited CA1 hippocampal LTP in slices from P15-25 rats, but this
effect was not observed in P70-100 rats (Swartzwelder et al., 1995a).
Furthermore, LTP was not impaired in P40-80 guinea pigs gestationally exposed
to EtOH during the third trimester-equivalent period (maternal blood EtOH
concentration 245 mg/dL) (Byrnes et al., 2004). Collectively, these studies
suggest that LTP is sensitive to acute EtOH exposure in preparations from young
rats and that, in the case of neonatal rats, repeated EtOH exposure causes an
LTP deficit that persists during withdrawal.
We found no difference in synaptic strength measured by AMPAR- and
NMDAR-mediated input-output curves, suggesting that the proposed enhanced
excitation occurring during the withdrawal period is not observed in this model of
EtOH exposure. This further indicates that synaptic strength is preserved with
our repeated EtOH exposure paradigm, possibly through homeostatic plasticity
mechanisms (Turrigiano and Nelson, 2004; Hou et al., 2008; Carpenter-Hyland
and Chandler, 2006; Swann, 2004). These homeostatic plasticity mechanisms
do not appear to be engaged when EtOH is administered in a binge-like fashion
to neonatal rats, where excitotoxicity mediated by NMDAR upregulation is the
likely mechanism of action of EtOH (Thomas et al., 2002). Future studies should
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examine whether exposure paradigms, which involve gradual administration of
EtOH, result in persistent learning and memory alterations and if these can be
ameliorated by NMDAR antagonists. Importantly, previous studies in P45-60
rats exposed to similar levels of EtOH (approximately 80 mM) during the third
trimester-equivalent period (P4-9), exhibited a persistent decrease in fEPSP
input-output curves in the CA1 hippocampal region of (Bellinger et al., 1999).
Taken together with our results, these finding suggest that homeostatic plasticity
mechanisms are only able to transiently maintain glutamatergic synaptic strength
and that it eventually becomes impaired during the juvenile period of rat
development.
The lack of an effect on glutamate release measured by paired-pulse
ratios is consistent with our previously reported effects of acute EtOH in the CA1
hippocampal region in brain slices from P7-9 rat pups (Puglia and Valenzuela, In
press). This study, along with the results presented here, suggests that acute or
repeated EtOH exposure during the third trimester-equivalent period does not
affect glutamate release in the CA1 hippocampal region. However, acute EtOH
exposure has been shown to inhibit glutamate release in the CA3 hippocampal
region of P3-10 rat pups (but not >P15) by means of inhibition of an N-type Ca2+
channel, indicating that there are region specific differences in the effects of
EtOH on presynaptic function (Mameli et al., 2005).
We investigated the effects of EtOH on glutamatergic synaptic strength, as
well as presynaptic glutamate release, and found that third trimester-equivalent
EtOH exposure did not affect either of these parameters. How then might EtOH
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be impairing LTP? The time-course of LTP showed that for the first 15-20 min
after LTP induction, there was no difference between the EtOH (70-86 mM) and
control group; however, after about 20 min, the fEPSPs in the EtOH group rapidly
decayed to or below baseline levels, while those in the control group remained
potentiated. This indicates that EtOH potentially impairs a process involved in
LTP maintenance. A candidate factor that has been shown to be involved in LTP
induction and maintenance during this developmental period is protein kinase A
(PKA) (Yasuda et al., 2003). The dependence of LTP on PKA activity has been
shown to be developmentally regulated, where inhibition of this signaling enzyme
leads to impaired LTP in P7-9 rat pups, but not in more mature animals (Yasuda
et al., 2003). The time course of LTP in the presence of a PKA inhibitor closely
resembles the time course of LTP in the EtOH group (70-86) (Yasuda et al.,
2003). Moreover, EtOH has been shown to affect PKA signaling, potentially
implicating this molecule as a target of developmental EtOH exposure (Yao et al.,
2002).
Future studies should address the mechanism by which this third-trimester
EtOH exposure paradigm leads to impaired LTP in brain slices from P7-9 rat
pups. We chose to focus on the third trimester-equivalent period because it is
associated with intense synaptic formation and refinement; however, since
women who consume EtOH are likely to do so throughout pregnancy, future
studies should model EtOH exposure through all trimesters of pregnancy. In
addition, studies presented here were performed in the presence of gabazine,
which blocks GABAA receptors. Previous studies in mature animals have shown
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that effects of EtOH on GABAergic signaling can play a role in alterations in LTP
(Schummers and Browning, 2001). Thus, future studies should address
developmental effects of EtOH with GABAergic transmission intact.
In conclusion, the studies presented here suggest that a third trimesterequivalent EtOH exposure paradigm leads to impaired synaptic plasticity in the
developing CA1 hippocampal region. In addition, these data indicate that not all
third trimester-equivalent EtOH exposure paradigms result in enhanced NMDAR
function during the withdrawal period. Synaptic plasticity mechanisms are
thought to be fundamental for the generation of appropriate synaptic connections
during development. Alterations in these processes present one mechanism that
could underlie the long-term deficits associated with FASD.
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Figure Legends
Figure 1. Third trimester-equivalent EtOH exposure paradigm. (A) Schematic
representation of the exposure paradigm where rat pups and their respective
dams were repeatedly exposed to EtOH vapor or air (control) for 4 hrs per day,
starting on P2 and continuing to P9. Brain slices for electrophysiology studies
were prepared from P7, P8 or P9 rat pups, immediately after the 4 hr exposure
period. (B) EtOH concentrations in the exposure (vapor) chamber. Note that in
most cases error bars are smaller than the symbol. (C) Serum EtOH
concentrations measured from trunk blood samples collected immediately after
euthanasia. The dashed line represents the legal intoxication limit (0.08 g/dL =
17.4 mM). (D) Average pup weight of control and EtOH vapor-exposed groups
as a function of postnatal day. * p<0.05, by Two-way ANOVA followed by
Bonferroni post hoc test.

Figure 2. Repeated in vivo EtOH exposure does not inhibit LTP in rat pups with
SEC’s of 21-32 mM. (A) Sample traces of glutamatergic fEPSP-responses from
brain slices of control and EtOH-exposed rat pups. Note that letters correspond
to time points indicated by the lines in Panel B. Scale bars 0.2 mV/5 ms. (B)
Time course of AMPAR-mediated fEPSPs before and after LTP induction in the
EtOH and control groups. (C) Summary of AMPAR-mediated fEPSP amplitude
after LTP induction (t = 50-55 min). *p<0.05 from one-sample t-test from 100%.
NS, not significant by unpaired t-test.
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Figure 3. Repeated in vivo EtOH exposure inhibits LTP in rat pups with SEC’s of
70-86 mM. (A) Sample traces of glutamatergic fEPSP-responses from brain
slices of control and EtOH-exposed rat pups. Note that letters correspond to time
points indicated by the lines in Panel B. Scale bars 0.2 mV/5 ms. (B) Time course
of AMPAR-mediated fEPSPs before and after LTP induction in the EtOH and
control groups. (C) Summary of AMPAR-mediated fEPSP amplitude after LTP
induction (t = 50-55 min). *p<0.05 from one-sample t-test from 100%. #p<0.05
by unpaired t-test.

Figure 4. Repeated in vivo EtOH exposure does not alter AMPAR- and
NMDAR- mediated input-output curves in rat pups with SEC’s of 70-86 mM.
Sample traces and input-output curves for AMPAR- (A, B; scale bar = 0.2 mV/5
ms) and NMDAR-mediated fEPSPs (C, D; scale bar = 0.5 mV/25 ms).

Figure 5. Repeated in vivo EtOH exposure does not affect AMPAR-mediated
fEPSP paired-pulse ratios. Sample traces of control (A) and EtOH (B) groups.
Scale bars 0.2 mV/10 ms (C) Scatter plot of paired-pulse ratios (AMPARmediated fEPSP2/fEPSP1).
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6. AMPA receptor-mediated synaptic transmission in the
CA1 hippocampal region of neonatal rats: unexpected
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Abstract
AMPA glutamatergic receptors (AMPAR) mediate the majority of fast
excitatory synaptic transmission in mature neurons. In contrast, a number of
developing synapses do not express AMPARs; these are gradually acquired in
an activity-driven manner during the first week of life in rats, which is equivalent
to the third trimester of human pregnancy. Neuronal stimulation has been shown
to drive high conductance Ca2+-permeable AMPARs into the synapse,
strengthening glutamatergic synaptic transmission. Alterations in this process
could induce premature stabilization or inappropriate elimination of newly formed
synapses and contribute to the hippocampal abnormalities associated with fetal
alcohol spectrum disorder. Previous studies from our laboratory performed with
hippocampal slices from neonatal rats showed that acute ethanol exposure
exerts potent stimulant effects on CA1 and CA3 neuronal networks. However,
the impact of these in vitro actions of acute ethanol exposure is unknown. Here,
we tested the hypothesis that repeated in vivo exposure to ethanol strengthens
AMPAR-mediated neurotransmission in the CA1 region via an increase in
synaptic expression of Ca2+-permeable AMPARs. We exposed rats to ethanol
vapor (serum ethanol concentration ~40 mM) or air for 4 hr/day from postnatal
day (P) 2 to 6. In brain slices prepared at P4-6, we found no significant effect of
ethanol exposure on input-output curves for AMPAR-mediated field excitatory
postsynaptic potentials (fEPSPs), the contribution of Ca2+-permeable AMPARs to
these fEPSPs, or the acute effect of ethanol on fEPSP amplitude. These results
suggest that homeostatic plasticity mechanisms act to maintain glutamatergic
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synaptic strength and ethanol sensitivity in response to repeated developmental
ethanol exposure.

Introduction
Ethanol exposure during development can result in fetal alcohol spectrum
disorder (FASD), which represents a broad range of clinical alterations (Green,
2007). These include learning and memory deficits that are, in part, a
consequence of damage to the hippocampal formation (Berman and Hannigan,
2000). Approximately 10% of pregnant women consume ethanol and ~2% binge
drink (Centers for Disease Control and Prevention (CDC), 2009). In addition,
about half of pregnant women who consume ethanol continue to do so through
the third trimester, a period of intense glutamatergic synaptic formation and
refinement (Khazipov et al., 2001; U.S. Department of Health and Human
Services, 1998). Ionotropic glutamatergic signaling is largely mediated by αamino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptors (AMPARs) and Nmethyl-D-aspartate receptors (NMDARs) (Dingledine et al., 1999). AMPARs
mediate synaptic transmission at the resting membrane potential and contribute
to removal of Mg2+ block from the NMDAR (Dingledine et al., 1999). The AMPAR
is a tetrameric receptor composed of various combinations of subunits (GluR1-4)
and the functional properties of the receptor are highly dependent on its subunit
composition. Receptors containing GluR1, 3 and/or 4 subunits are Ca2+permeable and susceptible to polyamine blockade (Donevan and Rogawski,
1995). When AMPARs contain a GluR2 subunit, they become Ca2+-impermeable
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as a result of the presence of a positively-charged arginine in the transmembrane 2 domain, which blocks Ca2+ entry and prevents blockade by
polyamines (Bassani et al., 2009).
Increases in spontaneous neuronal activity in hippocampal slice cultures
were shown to induce synaptic insertion of Ca2+-permeable (GluR4-containing;
higher conductance) AMPARs into CA1 pyramidal neurons, which are then
gradually replaced in an activity independent manner by Ca2+-impermeable
(GluR2-contaning; lower conductance) AMPARs (Zhu et al., 2000). Work from
our laboratory indicates that during the neonatal period of rat development, which
is equivalent to the third trimester of human pregnancy, ethanol paradoxically
acts as a potent stimulant of neuronal activity both in the CA3 and CA1
hippocampal regions (reviewed in Valenzuela et al., 2008). Acute ethanol
application in brain slices increased spontaneous network activity of CA3
hippocampal pyramidal neurons, which provide glutamatergic input to CA1
hippocampal pyramidal neurons (Galindo et al., 2005). Moreover, acute ethanol
exposure of slices from postnatal day (P) 3-5 rats induced the production and/or
release of a pregnenolone sulfate-like neurosteroid retrograde messenger that
decreases failures of AMPAR-mediated excitatory postsynaptic currents (EPSCs)
at Schaffer collateral-to-CA1 pyramidal neuron synapses under conditions of
minimal stimulation (Mameli et al., 2005; Mameli and Valenzuela, 2006). Based
on these results and those of Zhu et al. (2000), we hypothesized that repeated in
vivo exposure to ethanol would strengthen AMPAR-mediated neurotransmission
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in the CA1 region via an increase in synaptic expression of Ca2+-permeable
AMPARs.
To test this hypothesis, we used field recording techniques in the CA1
hippocampal region in brain slices from animals developmentally exposed to
ethanol vapor or air. We measured AMPAR-dependent field excitatory
postsynaptic potential (fEPSP) input-output curves to assess changes in synaptic
strength, and used a pharmacologic inhibitor of Ca2+-permeable AMPARs to
assess changes in the functional expression of these receptors. We also reexamined the acute effects of ethanol on AMPAR-mediated synaptic responses
and tested whether these acute effects were affected by repeated ethanol vapor
exposure.
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Experimental Procedures
Ethanol Vapor Chamber Exposure Paradigm
Animal procedures were approved by the Institutional Animal Care and
Use Committee of the University of New Mexico Health Sciences Center and
conformed to National Institutes of Health guidelines. Timed-pregnant SpragueDawley rats were obtained from Harlan (Indianapolis, IN). Neonatal rat pups and
dams were exposed to ethanol vapor as previously described (Galindo and
Valenzuela, 2006). Starting on P2, animals were transported to a room housing
the ethanol vapor chamber apparatus and weighed prior to exposure. Air tight
lids were then placed on the animals’ home cages (La Jolla Alcohol Research
Inc, La Jolla, CA) and were perfused with air (control group) or an air/ethanol
vapor mixture (ethanol group). Ethanol was vaporized using a heating flask that
receives a constant drip of 95% liquid ethanol (Tarr LLC, Phoenix, AZ) regulated
with a peristaltic pump. Ethanol vapor (or air) was continuously removed by an
exhaust hose connected to a vacuum line, maintaining constant ethanol vapor
levels. Litters were culled to 10 pups on P2 and exposed daily for 4 hrs per day
until P6 (Fig. 1A). Exposures were started at 07:00 hrs (lights on at 06:00 hrs and
lights off at 18:00 hrs). The P2-6 developmental period was chosen because it
encompasses the time frame where the acute stimulatory actions of ethanol were
detected in the CA1 and CA3 hippocampal regions (Galindo et al., 2005; Mameli
et al., 2005; Mameli and Valenzuela, 2006).

Tissue preparation and solutions
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Unless indicated, chemicals were from Sigma (St. Louis, MO) or Tocris
Cookson (Ellisville, MO). Both male and female rat pups were deeply
anesthetized with 250 mg/kg of ketamine and euthanized by decapitation
immediately after the 4 hr exposure on P4-6. Trunk blood samples were allowed
to coagulate and centrifuged at 2.3 x g for 10 min to obtain serum. Serum
ethanol concentrations were determined using an alcohol dehydrogenase-based
assay involving the reduction of NAD+ (β-NAD, free acid, grade I, Roche,
Indianapolis, IN). NADH absorbance was read at a wavelength of 340 nm.
Coronal brain slices (400 μm) were prepared using a vibratome, as previously
described (Mameli et al., 2005). After a recovery period of 45 min at 35-36ºC,
slices were stored for 1-8 hr at room temperature. Artificial cerebrospinal fluid
(ACSF) contained the following (in mM): 126 NaCl, 2 KCl, 1.25 NaH2PO4, 1
MgSO4, 26 NaHCO3, 2 CaCl2, 10 glucose, and 0.01 gabazine (also known as
SR-95531) equilibrated with 95%O2/5%CO2. When indicated, the ACSF also
contained 100 µM 1-naphthylacetyl spermine trihydrochloride (NASPM), 50 µM
D,L-2-amino-5-phosphonovaleric acid (AP5), 50 µM GYKI-53655 and/or 10 µM
2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo[f]quinoxaline-2,3-dione (NBQX).

Electrophysiological recordings
Recordings were performed in the CA1 stratum radiatum at 32ºC with a
perfusion rate of 2 ml/min using an Axopatch 200B amplifier (Molecular Devices,
Sunnyvalley, CA). Recording micropipette glass electrodes had resistances of 35 MΩ and were filled with ACSF. AMPAR fEPSPs were evoked using a
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concentric bipolar electrode (inner pole 25 µm; outer pole 125 µm; Frederick
Haer Company, Bowdoinham, ME) placed in vicinity of the Schaffer collateral
fibers. Input-output curves were measured at the start of all recordings, and, for
subsequent experiments, the stimulation intensity was set at 40-50% of the
intensity required to elicit maximal responses. Stimulus duration was 75 µs and
stimuli were delivered at 0.033 Hz.
Data Analysis
Data were acquired and analyzed with pClamp 9 (Molecular Devices,
Sunnyvale, CA) and GraphPad Prizm 4.0 (San Diego, CA). The short time
interval between the presynaptic volley and fEPSP prevented accurate
measurement of the slope in most experiments. Therefore, data were analyzed
using the fEPSP amplitude. For each experiment, baseline was defined as the
average of 20 fEPSPs immediately before drug application. For experimental
conditions, 10 fEPSPs immediately preceding the start of the ethanol washout or
the application of NBQX or GYKI-53655 were averaged for analysis. Statistical
analyses of pooled data were performed by Students t test, one sample t test vs.
a theoretical mean of zero or 100%, or repeated measure two-way ANOVA. A p
≤ 0.05 was considered to be statistically significant. Data are presented as mean
± SEM with the number of determinations (n) representing the number of
recordings. Data shown in Figs. 2-3 were obtained in slices from 9-10 pups from
5 different litters per treatment condition. Data shown in Fig. 4 were obtained in
slices from 2 pups from 2 different litters. Data shown in Fig. 5 were obtained in
slices from 4 pups from 1 litter each for the control and ethanol groups.
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Results
To model exposure to ethanol during the third trimester of human
pregnancy, rats were exposed to ethanol vapor during the neonatal period of
development (Fig 1A). Dams and rat pups were exposed to ethanol vapor daily
for 4 hr per day with the average chamber ethanol concentration ranging from
1.51 to 1.65 g/dL (Fig. 1B). This exposure resulted in elevated ethanol
concentrations in neonatal pups, and very low levels in dams (Fig. 1C). Daily
litter average pup weights were not different between the control and ethanol
groups (n=6 for control and n=6 for ethanol; not significant (N.S.) by repeated
measures two-way ANOVA; Fig. 1D).
In brain slices from control and ethanol-exposed animals, we recorded
AMPAR-mediated fEPSP input-output curves in the presence of gabazine (10
µM) and AP5 (50 µM) to measure changes in synaptic strength. There was no
significant difference between the control and ethanol-exposed groups (N.S. by
repeated measure two-way ANOVA; Fig. 2).
We then tested the effects of NASPM (a blocker of Ca2+-permeable
AMPARs) on AMPAR-mediated fEPSPs in slices from control and ethanol
exposed animals. Figs 3A-B show that NASPM reduced amplitudes of AMPARmediated fEPSPs to a similar extent in the control and ethanol groups. As
expected, the events were abolished by the AMPAR antagonist, GYKI-53655 (50
μM). The residual potential recorded in the presence of GYKI-53655 (or NBQX;
data not shown) corresponds to the presynaptic volley, which was not
significantly different between the control (0.12 ± 0.02 mV; n=12) and ethanol
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(0.12 ± 0.02 mV; n=14) groups (N.S. by unpaired t-test). The time course of the
effect of NASPM is shown in Fig. 3C, where after a stable baseline was recorded
in the presence of gabazine (10 µM) and AP5 (50 µM), NASPM (100 µM) was
applied for 15 min. In a subset of experiments, NASPM application was followed
by application of GYKI-53655 or the non-NMDA antagonist, NBQX (10 μM) (n=12
for control and n=14 for ethanol) confirming that the fEPSPs were AMPARmediated. The percent of functional Ca2+-permeable AMPARs (i.e. those lacking
GluR2) corresponds to the magnitude of inhibition of fEPSPs by NASPM, and
was 21 ± 1.9% (n=19) for the control and 17.8 ± 1.5% for the ethanol (n=21)
groups (N.S. by unpaired t-test). NASPM did not differentially inhibit the AMPARmediated fEPSPs at P4, P5 or P6 (i.e. 3, 4, or 5 ethanol exposures; N.S. by twoway ANOVA; Fig 3D). In addition, the effect of NASPM was not correlated with
the serum ethanol concentration (by linear regression; R2=0.02; slope not
significantly different from zero; Fig. 3E).
Mameli et al. (2006) showed previously that acute exposure to ethanol, at
concentrations as low as 15 mM, significantly decreased the failure rate of
AMPAR-mediated EPSCs in CA1 pyramidal neurons from P3-4 rats under
conditions of minimal stimulation; this effect was dependent on the release of a
pregnenolone sulfate-like neurosteroid. Here, we re-examined the acute effect of
ethanol on AMPAR-mediated synaptic transmission in the developing CA1 region
using extracellular recording techniques. Ethanol was bath-applied after a stable
baseline was obtained in the continued presence of gabazine (10 µM); note that
AP5 was omitted because the actions of the pregnenolone sulfate-like
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neurosteroid are NMDAR dependent (Mameli and Valenzuela, 2006).
Unexpectedly, we found that ethanol (40 mM) induced a small but significant
inhibition of the AMPAR-mediated fEPSP (-7.53 ± 1.49% with respect to the
average of baseline and washout; p<0.01; by one sample t-test v. zero, n=6; Fig.
4A-B).
Finally, we investigated whether ethanol vapor exposure affected the
acute sensitivity to ethanol of AMPAR-mediated fEPSPs. Since the acute effect
of 40 mM ethanol was small, we tested the acute effect of a higher ethanol
concentration (80 mM). In the presence of gabazine (10 µM) and AP5 (50 µM),
ethanol (80 mM) was bath-applied for 10 minutes (Fig. 5A-B). Acute ethanol
application significantly inhibited AMPAR-mediated fEPSPs by 13.07 ± 1.35%
and 10.02 ± 2.29% (from the average of baseline and washout) in slices from the
control and ethanol groups, respectively (n=8; p<0.01 by one sample t-test from
zero for both conditions). These values were not significantly different from each
other (N.S. by unpaired t-test).
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Discussion
A number of studies have demonstrated that developmental ethanol
exposure produces persistent alterations in AMPAR function in CA1 hippocampal
and medial septum/diagonal band neurons (Bellinger et al., 1999; Hsiao and
Frye, 2003; Wijayawardhane et al., 2007). However, to the best of our
knowledge, this is the first characterization of the effect of in vivo third trimesterequivalent ethanol exposure on AMPAR function in the CA1 hippocampal region
of neonatal rats. We used a vapor chamber ethanol exposure paradigm that
models repeated moderate-to-heavy maternal ethanol use during the third
trimester of human pregnancy. An advantage of this exposure paradigm is that
serum ethanol concentrations in the dams are low, resulting in undetectable
alterations in maternal care (Galindo and Valenzuela, 2006). Averaged individual
pup weight was not different between control and ethanol-exposed litters
suggesting that this exposure paradigm models FASD more closely than fetal
alcohol syndrome, which involves growth retardation. This exposure paradigm
focuses on a critical period of brain development, termed the brain growth spurt,
where most glutamatergic synapses are generated and refined. A limitation of
our study is that it models a relatively short period of the third trimesterequivalent of human pregnancy. Maternal ethanol use typically spans all three
trimesters and pregnant women rarely start drinking during the third trimester
(Centers for Disease Control and Prevention (CDC), 2009). However, this study
was undertaken to selectively assess the impact of repeated ethanol exposure
during the third trimester-equivalent because of the critical importance of this
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period for neuronal circuit maturation. Future studies should re-examine the
impact of ethanol exposure during all three trimesters on glutamatergic synaptic
transmission in the developing CA1 region.
Contrary to our hypothesis, the strength of AMPAR–mediated synaptic
transmission did not differ between control and ethanol-exposed animals. This
is surprising in light of the previous finding from our laboratory that acute
exposure to 15-75 mM ethanol induced the production and/or release of a
pregnenolone sulfate-like neurosteroid retrograde messenger that strengthened
AMPAR-mediated synaptic transmission in the CA1 region of neonatal rats
(Mameli and Valenzuela, 2006). However, when we re-examined this effect of
ethanol using field recording techniques, we found that AMPAR-mediated
fEPSPs were not potentiated, but rather inhibited, by acute exposure to ethanol.
Inhibitory effects of ethanol on AMPARs have previously been observed in both
the CA3 and CA1 hippocampal regions of neonatal rat pups (Mameli et al., 2005;
Puglia and Valenzuela, Submitted). Therefore, it is possible that the acute
effects of ethanol reported by Mameli and Valenzuela (2006) can only be
observed under certain experimental conditions in vitro —i.e. under minimal
stimulation in the whole-cell voltage-clamp configuration with K+ channel blockers
present in the internal solution. These conditions could favor the detection of the
neurosteroid-dependent stimulatory actions of ethanol because of two reasons.
First, excitatory postsynaptic currents evoked under conditions of minimal
stimulation are likely mediated by AMPARs located in the proximal dendrites
and/or soma of CA1 pyramidal neurons and these receptors could be affected by

105

ethanol differently than the more distal receptors sampled in the fEPSP
recordings. Second, K+ channel inhibition could facilitate ethanol-induced
dendritic release of the pregnenolone sulfate-like neurosteroid. It is also possible
that the stimulatory effects of ethanol on CA3 network activity that were
previously reported by Galindo et al. (2005) are also dependent on the
experimental conditions. However, this possibility is unlikely given that these
effects were observed with whole-cell electrophysiological recordings in single
neurons, and also with Ca2+ imaging techniques in ensembles of CA3 neurons.
An alternative explanation for the lack of an effect of neonatal ethanol
vapor exposure on AMPAR-mediated transmission in the CA1 region is that
ethanol stimulates CA1 and CA3 neuronal activity in vivo, but neurons adapt to
these effects; i.e., homeostatic plasticity mechanisms may act to restore synaptic
strength (Carpenter-Hyland and Chandler, 2006). Our finding that the acute
effect of ethanol on AMPAR-mediated fEPSPs is not affected by vapor chamber
ethanol exposure suggests that these homeostatic mechanisms do not involve
the development of AMPAR tolerance to ethanol. This conclusion is also
supported by the finding of Galindo et al. (2006) that CA3 pyramidal neurons did
not develop tolerance to the excitatory actions of ethanol after repeated ethanol
vapor exposure. Moreover, lack of development of AMPAR tolerance to the
acute effects of ethanol was also observed in a study with medial
septum/diagonal band neurons from P15-25 and P32-35 rats that were exposed
to ethanol on P4-9 (blood ethanol level = 352 ± 9 mg/dL) (Hsiao and Frye, 2003).
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It was also unexpected that third trimester-equivalent ethanol exposure did
not alter the functional expression of Ca2+-impermeable AMPARs. In
hippocampal slice cultures from neonatal rats, it has been shown that increased
spontaneous excitatory activity induces synaptic trafficking of Ca2+-permeable,
GluR4-containing AMPARs (Zhu et al., 2000). Consistent with this, we predicted
that our ethanol exposure paradigm would repeatedly excite CA1 and CA3
neuronal networks, thus resulting in increased expression of Ca2+-permeable
AMPARs at CA1 pyramidal neuron synapses. As discussed above, repeated
ethanol exposure could initiate homeostatic plasticity mechanisms that would
prevent changes in synaptic expression of Ca2+-permeable AMPAR (Lissin et al.,
1998; Watt et al., 2000). Alternatively, it is possible that the paradigm of slice
preparation immediately after ethanol exposure led to GluR4 insertion and
subsequent exchange of this subunit with the Ca2+-impermeable GluR2 subunit.
Although the activity-independent exchange of GluR4 with GluR2 has indeed
been documented, this possibility is unlikely because this is an activityindependent slow process that can take up to 30 hrs and we measured
expression of Ca2+-permeable AMPARs less than 8 hrs after ethanol exposure
(Zhu et al., 2000). Moreover, if this exchange process had taken place, we
should have observed an increase in AMPAR fEPSP input-output curves
mediated by increased synaptic expression of GluR2-containing receptors.
In conclusion, our findings show that the in vitro acute stimulatory actions
of ethanol on developing CA1 pyramidal neurons occur under some, but not all,
experimental conditions. If these actions of ethanol take place in vivo, the long-

107

lasting impact on AMPAR-mediated synaptic transmission in the CA1 region
remains unknown. Moreover, AMPAR-mediated responses can be inhibited by
acute ethanol exposure in this region and this effect is not affected by long-term
ethanol vapor exposure. This finding confirms that AMPAR-mediated responses
are important targets of the developmental actions of ethanol and that these
responses are not subject to the acquisition of ethanol tolerance. Future studies
should examine whether ethanol alters the normal functioning of other
neurotransmitter receptors or intracellular signaling pathways during the third
trimester of pregnancy, as these could have deleterious consequences on the
maturation of hippocampal neuronal networks and play a role in the learning and
memory alterations that characterize FASD.
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Figure Legends
Figure 1. Third trimester-equivalent ethanol exposure paradigm. (A) Schematic
representation of the exposure paradigm where rat pups and their respective
dams were repeatedly exposed to ethanol vapor for 4 hr per day. Exposure(s)
started at P2 and continued to P6. Brain slices for electrophysiology studies
were prepared from P4, P5 or P6 rats, immediately after the 4 hr exposure
period. (B) Ethanol concentrations in the exposure (vapor) chamber. (C) Serum
ethanol concentrations measured from trunk blood samples collected
immediately after euthanasia. Line represents the legal intoxication limit (17.4
mM). (D) Average pup weight of control and ethanol vapor-exposed pups as a
function of postnatal day.

Figure 2. Third trimester-equivalent ethanol exposure does not alter synaptic
efficacy in the CA1 hippocampus of P4-6 rat pups. (A) Representative traces of
AMPAR fEPSPs recorded at increasing stimulus intensities. (B) Pooled data of
control and ethanol exposed animals.

Figure 3. Third trimester-equivalent ethanol exposure does not alter functional
expression of Ca2+-permeable AMPARs. Representative traces of fEPSP
recordings from the control (A) and ethanol (B) groups obtained in the presence
of gabazine (10 µM) and AP5 (50 µM), followed by NASPM (100 µM) and then by
GYKI-53655 (50 µM). (C) Time course of the effect of NASPM application
followed by GYKI-53655 (or NBQX 10 µM) application. Letters above the time
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course correspond to letters in sample traces (a, b and c). (D) NASPM-mediated
inhibition of fEPSP amplitude as a function of postnatal day. (E) NASPMmediated inhibition of fEPSP amplitude as a function of the serum ethanol
concentration.

Figure 4. Acute Ethanol (40 mM) inhibited fEPSP responses in slices from naïve
P4 rats. (A) Sample traces from fEPSP recordings and (B) time course.
Recordings were performed in the presence of gabazine (10 µM) and fEPSPs
were inhibited by NBQX (10 µM). Letters above the time course correspond to
letters in sample traces (a, b, c, and d).

Figure 5. Third trimester-equivalent ethanol vapor exposure does not induce
tolerance to the acute inhibitory effects of ethanol on the amplitude of AMPARmediated fEPSPs. Ethanol (80 mM) was bath-applied to brain slices from P4-6
rat pups. (A) Sample traces from fEPSP recordings and (B) time course.
Recordings were performed in the presence of gabazine (10 µM) and AP5 (50
µM). Letters above the time course correspond to letters in sample traces (a, b,
and c).
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7. Conclusions
7.1 Summary of main findings
The main findings of this dissertation project can be summarized as
follows. First, acute EtOH application reduced AMPAR- and NMDAR-mediated
responses, as well as LTP induction, in the CA1 hippocampal region during the
late portion of the third trimester-equivalent period (P7-9). In addition, acute
EtOH application did not affect glutamate release. Second, at P7-9, LTP was
impaired during early withdrawal following a repeated in vivo third trimesterequivalent EtOH exposure paradigm. Measures of NMDAR- and AMPARmediated synaptic strength were not different than controls, nor were measures
of presynaptic glutamate release. Lastly, repeated in vivo third trimesterequivalent EtOH exposure did not affect AMPAR-mediated synaptic strength,
expression of Ca2+-permeable AMPARs, or induce tolerance to the acute
inhibitory effects of EtOH during the early portion of the third trimester-equivalent
period (P4-6). Main findings from chapters 4-6 are summarized in table 7.1.
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LTP (3x100Hz)

Glutamate release

NMDAR responses

AMPAR responses

fEPSPs (P7-9; 40-80mM; increased effect
2+
in presence of Mg

 Induction (P7-9; 80mM)

 PPR AMPAR-fEPSP; (P7-9; 80mM)



 Tolerance to acute EtOH (P4-6; 80mM)

EPSCs (P7-9; 80mM; perforated-patch)



 Expression/maintence (P7-9; 70-86mM)

 PPR AMPAR-fEPSP (P7-9; 70-86mM)

 fEPSPs I/O curve (P7-9; 70-86 mM)

Ca -permeable AMPAR expression (P4-6;
23-63mM)

2+



EPSCs (P3-4; >15mM; minimal stimulation;
Mameli et al. (2006)



 fEPSPs I/O curve (P4-9; 23-86 mM)

fEPSPs (P4-9; 40-80mM; Total=Ca impermeable)

2+

Chronic



Acute

Table 7.1. Summary of the effects of EtOH on the neonatal CA1 hippocampal region.

7.2 Overall conclusions
Glutamatergic synaptic transmission and plasticity are sensitive targets of
EtOH during the third trimester-equivalent. Studies in this dissertation provide
insight as to the developmentally-regulated and brain region specific effects of
EtOH on glutamatergic signaling and plasticity during the third trimesterequivalent period. These data add to a growing body of evidence indicating that
significant differences exist between the effects of EtOH on the developing
versus the mature brain, confirming that conclusions from studies in mature
animals may not be applicable to those during development.
One example is the developmental effects of EtOH on AMPAR-mediated
transmission in the CA1 hippocampal region. Studies in chapter 4, as well as
work from others, demonstrate that AMPAR-mediated transmission in this region
is relatively insensitive to the actions of EtOH in mature animals (Randall et al.,
1995; Lovinger et al., 1990; Carta et al., 2003). However, during the third
trimester-equivalent period, we found AMPAR-mediated responses to be
sensitive to the acute actions of EtOH. These results were consistent with
previous studies from our lab showing acute inhibitory effects of EtOH in the CA3
region, but are in contrast to results obtained in cortical layer 2/3 neurons during
this period (Mameli et al., 2005; Sanderson et al., 2009). Another example is the
effects of EtOH on NMDAR-mediated transmission. Studies presented here
found inhibition of NMDAR-mediated transmission during the third trimesterequivalent, consistent with what is found in the mature animal in the CA1
hippocampal region. However, during the third trimester-equivalent in the CA3
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hippocampal region and cortical layers 2/3, NMDAR-mediated transmission was
relatively insensitive to EtOH. These data suggest that the effects of EtOH are
developmentally regulated in some but not all brain regions (Mameli et al., 2005;
Sanderson et al., 2009). Additionally, the effects of EtOH on glutamate release
during the third trimester-equivalent period also demonstrate brain region specific
differences. Previous studies found inhibition in the CA3 region, but in the CA1
region there was no effect. Collectively, these studies highlight not only
developmental differences in the sensitivity to the acute effects of EtOH, but also
brain region specific differences.
Interestingly, the chronic effects of EtOH exposure are different from what
occurs in more mature animals, in some, but not all regards. In mature animals,
chronic EtOH exposure results in neuroadaptation of NMDAR-mediate responses
(Thomas and Riley, 1998). Roberto and colleagues (2004) found that glutamate
release, as well as NMDAR-mediated postsynaptic responses, were enhanced in
the central amygdala during early EtOH withdrawal from EtOH vapor exposure
(Roberto et al., 2004). Furthermore, sensitization to acute EtOH was observed in
NMDAR-mediated responses (Roberto et al., 2004). Nelson and Gruol (2005)
found increased NMDAR-mediated responses and expression in the CA1
hippocampal region after 7 days of EtOH withdrawal (Nelson et al., 2005).
However, studies presented here demonstrate a lack of adaptation after repeated
rounds of in vivo EtOH exposure for all parameters tested (glutamate release,
NMDAR-, and AMPAR-mediated synaptic strength, and tolerance of AMPAR-
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mediated responses to acute EtOH exposure), suggesting differences in
response to repeated EtOH-mediated neuronal insults during development.
LTP expression and/or maintenance in the CA1 hippocampus was
impaired with a third trimester-equivalent exposure paradigm. This was
consistent with studies of Roberto and colleagues (2002) with mature animals
chronically exposed to EtOH showing impaired LTP in the CA1 hippocampus
(Roberto et al., 2002). However, Fujii and colleagues (2008) demonstrated a
decreased threshold for LTP induction in the CA1 hippocampus of mature rats
exposed chronically to EtOH and this appeared to be a result of decreased
GABAergic tone and increased NMDAR-activity (Fujii et al., 2008). The authors
address the discrepancy between their findings and those of Roberto and
colleagues (2002) as attributable to differences in EtOH exposure paradigm and
blood EtOH levels. In adults, impairments in glutamatergic signaling and
synaptic plasticity by chronic and acute EtOH intoxication are likely to contribute
to memory loss, anxiety, seizures, dependence, neuronal damage, and cognitive
impairments (Saitz, 1998; Siggins et al., 2003; Vengeliene et al., 2008).
However, EtOH exposure during the third trimester-equivalent period is likely to
cause impaired synapse formation and refinement in the immature brain, and
impaired network formation (among other processes) likely contributing to the
spectrum of mental retardation, behavioral problems and cognitive impairments
observed in children afflicted by FASD (Berman and Hannigan, 2000; Voigt et al.,
2005; Bellinger et al., 1999).
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7.3 Basic and Clinical implications
Deficits in learning and memory and behavior disorders have been
observed in children with exposure levels of less than 2 standard drinks per day
(Olson et al., 1997; Sood et al., 2001). Similarly, an animal study found that
prenatal exposure to low concentrations of EtOH (blood alcohol levels near 0.03
g/dL) caused relatively subtle deficits in learning and memory that were detected
in a modified version of the Morris water maze test (Savage et al., 2002).
Studies proposed in this dissertation support the notion that alterations in
glutamatergic signaling and plasticity could contribute to long-term learning and
memory deficits in adult animals; however, why do we observe impairments in
LTP during development only with elevated doses although cognitive impairment
can be detected in animals exposed to lower doses? This may be related to the
recording conditions used in our studies. For example, the paradigm that we
used to induce LTP does not mimic patterns of neuronal activity that induce
plasticity under physiological conditions, and it is possible that the latter is more
sensitive to EtOH than experimentally-induced LTP. Alternatively, EtOH-induced
behavioral deficits could be a consequence of alterations in multiple
neurotransmitter systems across developing neuronal networks.
An elegant study of cultured hippocampal neurons demonstrated that
when neurons were subjected to prolonged inhibition of AMPARs by NBQX—
which possibly mimics what occurs with chronic in vivo EtOH exposure in the
CA1 region—there was compensatory increases in postsynaptic AMPAR
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expression (Thiagarajan et al., 2005). This raises the question of why we did not
observe compensatory upregulation in AMPAR-mediated responses in our
chronic EtOH exposure studies. An indication of what is potentially occurring
comes from studies of developing hippocampal neurons in culture. When
individual neurons were transfected with a Kir potassium channel, which
hyperpolarized the neuron, there was homeostatic regulation normalizing firing
rates in neurons with existing synaptic connections. However, when transfection
occurred in neurons before synapse formation, the result was an overall
reduction in synaptic inputs (Burrone et al., 2002). Therefore, it is possible that
homeostatic increases in AMPAR expression at the single synapse level
occurred during our EtOH exposure paradigm but that the impact of this effect
was offset by a reduction in synapse number, resulting in an undetectable
change in synaptic strength. This is supported by the studies of Bellinger and
colleagues (1999) as previously discussed, where a third-trimester EtOH
exposure paradigm led to decreased synaptic efficacy in mature animals, which
was interpreted to be a consequence of a decrease in synapse number (Bellinger
et al., 1999).
Homeostatic plasticity mechanisms act to preserve synaptic strength, yet
we did not observe NMDAR “upregulation” in response to EtOH-induced
inhibition of these receptors, as proposed by Thomas and Colleagues (2002 and
2004). As discussed in Chapter 5, this could be due to differences in the EtOH
exposure paradigm (binge vs. gradual EtOH administration). However, a
question is how does NMDAR antagonism protect against learning and memory
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deficits in mature animals that were exposed to EtOH in a binge-like fashion
during the 3rd trimester-equivalent (Thomas et al., 2002; Thomas et al., 2004)?
Clues to this may come from the negative regulatory effects of NMDARs on
AMPAR transcription and translation, degradation, association with accessory
proteins, and maintenance of silent synapses (Hall and Ghosh, 2008). The use
of these NMDAR-inhibiting agents may allow synapses that were not stabilized
due to EtOH-mediated impairments, a “second chance” to become stabilized via
increases in AMPAR-mediated transmission and expression of accessory
proteins involved in synaptic formation and maintenance, presenting a possible
clinical therapeutic target in FASD (Hall et al., 2007; Adesnik et al., 2008).
Although many mechanisms have been proposed for EtOH-mediated
impairments in CNS function, it is becoming clear that alterations in the normal
assembly of neuronal circuitry plays an important role in the mechanism of action
of EtOH. Studies presented here, as well as work from others, support the notion
that impairments in glutamatergic signaling and synaptic plasticity during the third
trimester-equivalent period are a target of EtOH, and in part, contribute to the
long-term deficits observed in FASD.
FASD is often described as a preventable disease (Medina and Krahe,
2008; Ripabelli et al., 2006; Payne et al., 2005; Krulewitch, 2005), and indeed
efforts to heighten awareness about the consequences of EtOH consumption
during pregnancy have had some limited success (Abel, 1998). In spite of this, a
substantial portion of women drink during pregnancy (Muhuri and Gfroerer,
2009). Therefore, therapeutic interventions for FASD need to target several

123

areas such as reducing/preventing maternal ethanol consumption, ameliorating
the effect of EtOH during fetal development and treating the long-lasting
consequences of EtOH exposure. Clinical therapies for children afflicted with
FASD have shown some efficacy and these include behavioral, social,
educational, and pharmacologic interventions (Reviewed in Peadon et al., 2009).
New therapeutic interventions are being developed with the aid of animal models
of FASD; for example, studies with rats have shown improvements in learning
and memory and hippocampal dendritic spine density with environmental
enrichment and voluntary exercise (Thomas et al., 2008; Hannigan et al., 1993;
Berman et al., 1996). However, these interventions have yet to be translated into
the clinic.
The data support that the long-term deficits induced by developmental
EtOH exposure are founded in alterations in developmental processes such as
glutamatergic signaling and network formation as addressed here, and “post hoc”
treatments may have limited efficacy. Encouragingly, animal models of prenatal
EtOH exposure have shown reversal of learning and memory deficits when the
nootropic agent, aniracetam (positive allosteric modulator of AMPARs) was
administered during early life after prenatal EtOH exposure (Vaglenova et al.,
2007). Furthermore, another pharmacologic agent, vinpocetine
(phosphodiesterase 1 inhibitor), was been shown to restore impairments in
ocular dominance plasticity induced by third trimester-equivalent EtOH exposure
(Medina et al., 2006). Clearly, future research is needed toward the development
of effective therapeutic interventions against FASD.
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Attempts to mitigate EtOH-mediated deficits during in utero development
are potentially one of best avenues of treatment. Within this developmental
window, the third trimester is believed to be the period of highest susceptibility to
the teratogenic effects of EtOH (Livy et al., 2003a; Berman and Hannigan, 2000;
Thomas et al., 2002; Galindo and Valenzuela, 2006; Krahl et al., 1999; Thomas
et al., 2008; Olney et al., 2001; O'Leary-Moore et al., 2006; Hunt et al., 2009;
Tsuji et al., 2008). Choline supplementation during prenatal and early postnatal
development has been shown to be protective in a number of areas, including
growth retardation as well as learning and memory impairments (Thomas et al.,
2000; Thomas et al., 2009). In addition, studies have shown that NMDAR
inhibition after third trimester-equivalent EtOH exposure protects against learning
and memory deficits (Thomas et al., 2002). However, the use of
pharmacotherapy against the effects of EtOH described here, such as, restoring
synaptic plasticity with a positive modulator of AMPARs, presents inherent
problems. Maturation of neuronal circuits occurs at different time points in the
brain, and unless region specific targeting of the ameliorative agent can be
achieved, benefit is questionable due to the likelihood that unwanted side effects
may occur. Furthermore, compliance issues would likely be encountered with
pregnant women who use/abuse EtOH. Nonetheless, understanding the basic
pathophysiology of the developmental actions of EtOH remains paramount in
designing effective therapies against FASD.
What are the first steps in dealing with maternal EtOH consumption?
When a pregnant woman seeks prenatal care, the first thing that needs to be
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addressed is maternal substance abuse. Although it is advocated by the
American College of Obstetricians and Gynecologists that all pregnant women
are screened for this, approximately 35-55% of women in two studies reported
that questions related to substance abuse were not asked during prenatal care
visits (Hankin et al., 2000). Pregnancy presents a unique opportunity to provide
interventions to alcoholic women due to increased maternal motivation to have a
“healthy” baby (Hankin et al., 2000). Although FAS and FASD have been
described as “preventable”, the underlying pathology is often EtOH-dependence
and addiction, which are difficult to prevent and treat (Rayburn and Bogenschutz,
2004). In non-pregnant women, several approaches, including
pharmacotherapy, have shown clinical efficacy in treating alcohol-dependence;
however, the majority of these pharmacologic agents negatively affect the
offspring, effectively making them unsafe for use while pregnant (Rayburn and
Bogenschutz, 2004). Thus, in addition to counseling by the primary health care
provider, alternative psychosocial interventions include Alcoholics Anonymous
and family service agents (Lui et al., 2008). If women are unable to quit drinking,
data presented here, support the notion that any attempt to reduce maternal
EtOH consumption likely has beneficial effects with regard to the developing
fetus.

7.4 Critique and future directions
Slice preparation and recording conditions
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For the preparation of the brain slices used in the studies described here,
animals were euthanized after anesthesia with ketamine (NMDAR-antagonist).
In addition to its sedative/hypnotic effects, ketamine has also been shown to
induce cell death in the hippocampal region, potentially affecting
electrophysiological recordings and this must be kept in mind when interpreting
our results (Hayashi et al., 2002; Young et al., 2005). The acute slice
preparation has many advantages as discussed in Chapter 3; however, neuronal
connections are inevitably severed, and synaptic inputs that can be studied are
limited to those preserved in the brain slice. In addition, because the sections
are relatively thin, there is an increased exposure of cells to the ACSF; therefore,
diffusible neuromodulators that affect glutamatergic signaling and plasticity (e.g.
BDNF, nitric oxide, endocannabinoids) could potentially be washed out.
The recordings presented here were performed under pharmacologically
isolating conditions, which included inhibitors of GABAergic transmission.
Studies in mature animals have shown that effects of EtOH on GABAergic
signaling can play a role in alterations in LTP (Schummers and Browning, 2001).
Thus, future studies should address developmental effects of EtOH with
GABAergic transmission intact, as well as the roles of alterations in other
neurotransmitter systems in the mechanism of action of EtOH. In addition,
pharmacological agents were used to elucidate the effects of EtOH on Ca2+impermeable AMPARs, and inferences were made as to the effects on Ca2+permeable AMPARs by using the effect on the total population as a reference.
Experiments using genetic manipulation techniques, such as point mutations in
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the GluR2 subunit of AMPARs making all AMPARs Ca2+-permeable, would be
required to more directly address the effects of EtOH on this subpopulation of
receptors. Alternative approaches could include miRNA approaches aimed at
knocking down the enzyme (adenosine deaminase) that causes mRNA editing of
the GluR2 subunit, leading to the insertion of an arginine instead of a glutamine
in the intracellular portion of the M2 domain.
The rapid rise and fall in EtOH concentrations that occurs with bath
perfusion is not physiologic, and studies have shown differential effects of
synaptic plasticity with gradual (over 75 min) increases in EtOH concentrations in
the CA1 hippocampal region (Tokuda et al., 2007a). In addition to this, acute
studies of EtOH actions, such as those described in this dissertation, do not
assess the potential contributions of products of EtOH metabolism, such as
acetaldehyde, which has been postulated to contribute to the deficits observed in
FASD (Hard et al., 2001). We attempted to address this issue by using an in vivo
exposure paradigm; however, this shortcoming must be kept in mind when
interpreting data from our acute EtOH application studies.

Recording techniques
The majority of studies in this dissertation use the field recording
technique. Advantages of this approach include that data are collected as an
average of responses over a population of neurons. On the other hand, this very
advantage is a limitation in regards to not being able to detect what is occurring
at the level of the individual neuron. Furthermore, field recordings during the
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early developmental period have inherent problematic issues. In the majority of
recordings, the fiber volley overlaps with the field response, thus making the
preferred method of quantification (e.g. initial fEPSP slope) difficult to implement.
In addition, the fiber volley was significantly contaminated by the rising phase of
the fEPSP, making it difficult to ascertain whether EtOH affected the presynaptic
volley, leading to indirect inhibition of the fEPSP. This is addressed in detail in
Chapter 8.6 and Appendix fig 8.6; briefly, exploration of this issue revealed that
the presynaptic volley is not directly affected by EtOH and that the decrease in its
amplitude is a consequence of EtOH-induced inhibition of the fEPSP.
Another uncertainty that must be kept in mind when interpreting our
results is that measures of glutamate release were performed using paired-pulse
plasticity that, although commonly used, do not directly measure glutamate
release (Hanse and Gustafsson, 2001). Future studies using quantum dots or
FM dyes should be employed to confirm that EtOH does not affect glutamate
release at developing CA1 synapses.
In our studies, synaptic plasticity was induced using a high frequency
stimulation paradigm (HFS; e.g. 100Hz). Although this HFS paradigm replicates
in vivo changes at the level of glutamate receptors that occur with learning and
memory in the hippocampus, LTP is not induced by this type of stimulation under
physiological conditions in the intact developing brain (Whitlock et al., 2006).
The physiological mechanism that is thought induce plasticity during
development involves large GABAergic and glutamatergic driven bursting
patterns thought to originate in the CA3 region and propagate to the CA1. These
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bursting patterns provide the correlated network-activity and neuronal
depolarization necessary to stabilize synaptic connections. (Leinekugel et al.,
1997; Ben-Ari, 2001; Leinekugel, 2003). Elegant studies have shown that pairing
afferent stimulation with this bursting activity leads to induction of LTP. It would
be interesting to assess the effect of EtOH on plasticity induced by this type of
stimulation in the developing hippocampus (Kasyanov et al., 2004; Mohajerani et
al., 2007). In addition, exciting future experiments would be to further investigate
the effects of developmental EtOH exposure on plasticity using in vivo recording
techniques in neonatal animals; however, these studies must await the
development of less invasive recording techniques that minimally disrupt
neonatal behavior and maternal-pup interactions. Furthermore, experiments
addressing changes at the individual synapse level using 2-photon imaging and
laser-induced glutamate uncaging could be useful in establishing whether
synaptic strength at individual synapses is increased.
In studies presented in this dissertation, it was concluded that the
inhibitory effects of EtOH on LTP induction were likely postsynaptic due to the
lack of presynaptic changes in glutamate release probability as discussed in
chapters 4 and 6. This was based upon data from paired-pulse plasticity studies;
however, it is also a possibility that the effects occur as a result of EtOHmediated impairments in the LTP induction paradigm. Future studies should
address the effects of EtOH on the LTP induction paradigm using whole-cell or
perforated patch-clamp recording techniques and measure Ca2+ influx triggered
by the induction paradigm in the presence and absence of EtOH. There is a
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relationship between Ca2+ concentration and the change in synaptic strength, by
which high synaptic concentrations lead to LTP, whereas low synaptic
concentrations (as well as extrasynaptic) leads to LTD. Thus, measuring the
effects of EtOH on this parameter would assess effects on the induction
paradigm.
Additionally, the conclusion that repeated in vivo EtOH exposure does not affect
synaptic strength was based on data from AMPAR- and NMDAR-mediated inputoutput curves. However, as described in chapters 4-6, our studies did not
account for changes in the presynaptic volley and therefore should be addressed
as synaptic excitability rather than synaptic strength. To address this, NMDARmediated fEPSPs do demonstrate a clear presynaptic volley and data were
reanalyzed after normalization to this parameter (Chapter 8.8). There was no
significant difference in NMDAR-mediated input-output curves between control
and EtOH exposed animals suggesting that there is no change in synaptic
strength, but uncertainty remains with regard to AMPAR-mediated responses.
Future experiments as previously discussed above should be used to address
this uncertainty.
Exposure paradigm
Although advantageous in many respects, the vapor chamber inhalation
paradigm has limitations with regards to the route of EtOH administration. For
instance, the role of the maternal-fetal interface in the mechanism of action of
EtOH during the 3rd trimester-equivalent cannot be assessed with this method.
Although we did not observe differences in growth progression, the long-term
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effects of EtOH on lung development and gas exchange have not been studied.
Additionally, this route of EtOH entry into the developing animal bypasses
hepatic metabolism that occurs with other third trimester-equivalent models of
EtOH exposure (“pup in the cup” and intragastric gavage); however, vapor
chamber exposure more closely mimics the flow of blood from
placentaumbilical veinductus venosusinferior vena cavabrain in the
developing human fetus. Thus, it is important to keep this point in mind when
comparisons across studies are being made.
It is also important to note that the exposure paradigm modeled here is
only one of many drinking patterns pregnant women engage in—others include
low-dose consumption with meals and heavy binge drinking during weekends. In
addition, our studies only addressed effects during the early withdrawal period. It
is possible that adaptive changes are delayed in their expression, and future
experiments should address the effects of prolonged withdrawal in these animals
(Nelson et al., 2005). In addition, future studies should also investigate EtOH
effects throughout pregnancy including the first and second trimester-equivalent
periods. Furthermore, future studies modeling co-drug use such as nicotine,
marijuana, cocaine, etc. may more accurately describe what occurs in the human
population. During pregnancy, 16.8% of women report cigarette use, 2.8% report
marijuana, and 0.3% report cocaine (including crack) use (Muhuri and Gfroerer,
2009). Another caveat associated with FASD is that environmentally-induced
stress is often associated with developmental EtOH exposure, which likely
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enhances the detrimental effects of EtOH on the developing fetus (Choi et al.,
2008; Weinberg et al., 2008; Kinsella and Monk, 2009).

Behavioral relevance and long-lasting effects of this paradigm

Studies presented here only address synaptic function. An interesting future
direction would be to replicate the learning and memory deficits observed by
Thomas and colleagues (2002) using the vapor chamber exposure paradigm
(Thomas et al., 2002). Furthermore, studies aimed at observing deficits with
lower doses of EtOH using more rigorous behavioral testing methods—such as
those developed in the Morris laboratory—coupled with more sensitive assays of
neuronal function should be performed in the future (Bast et al., 2005).
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8. Appendix

8.1. The effects of acute EtOH exposure on Long Term
Depression (LTD) in the CA1 hippocampus of P7-9 rat pups
8.1.1. Purpose of the experiment
EtOH (80mM) was shown to affect the induction of LTP in the
hippocampus in acute slices of P7-9 rat pups. These experiments examined
whether EtOH also affected the induction of LTD.

8.1.2. Methods
Field EPSP slice recordings from the CA1 hippocampal region were
performed as described in chapter 4. When indicated, the ACSF contained
gabazine (10 µM) AP5 (50 µM), and/or LY 367385 (LY; 50 µM; mGluR1
antagonist). LTD induction was performed by delivering a 5 Hz stimulus train for
3 min. Test pulses were delivered every 30 s. Stimulus duration was 75 µs, and
the paired-pulse interval was 50 ms. Data were analyzed using a one sample ttest v. 100%. Baseline corresponded to the 20 sweeps immediately preceding
the application of EtOH, and the test condition corresponded to the last 20
sweeps of the recording, which was at least 35 min from the LTD induction
protocol. The fEPSP peak amplitude was used for analysis. Data are presented
± SEM.
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8.1.3. Results
Figure 8.1.A shows the time course of the LTD induction paradigm, and
8.1.B shows the time course for the paired-pulse ratio. Fig 8.1.C. shows that,
under control (gabazine) conditions, the LTD protocol significantly reduced
fEPSP amplitude to 80.5 ± 5.3% of baseline (n=7; p<0.05 by one sample t-test v.
100%). In addition, there was a significant increase of 113.6 ± 2.3 (p<0.01; by
one sample t-test v. 100%) in the paired-pulse ratio. We then tested if EtOH (80
mM) affected this LTD induction paradigm and glutamate release. When this
LTD protocol was administered in the middle of the EtOH application (in the
presence of gabazine), fEPSPs were reduced to 74.4 ± 3.2 of baseline (n=7;
p<0.01 by one sample t-test v. 100%). There was a significant increase of 116.2
± 4.5 (p<0.05; by one sample t-test v. 100%) in the paired-pulse ratio. LTD in the
presence of EtOH was not significantly different from LTD in its absence; the
increase in the paired-pulse ratios was also not significantly different (NS by
unpaired t-test).
We then attempted to elucidate the mechanism for this LTD induction. We
first attempted to see if it was NMDAR dependent. Using gabazine and AP5, we
found that fEPSPs were significantly inhibited to 85.3 ± 2.3% of baseline (n=6;
p<0.01 by one sample t-test v. 100%). However, there was no significant change
in the paired-pulse ratio (100.3 ± 2.4%; NS by one sample t-test v. 100%). We
then tested if this effect was mGluR1 dependent and found that an antagonist of
this receptor did not affect LTD recorded in presence of AP5 and gabazine;
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fEPSPs were significantly reduced to 85.0 ± 4.3 (n=8; p<0.05 by one sample ttest v. 100), and the paired-pulse ratio was not affected 103.4 ± 3.0% (NS by one
sample t-test v. 100%).

8.1.4. Conclusions
Studies have shown that LTD induction mechanisms are developmentally
regulated; in P8-15 rats, the mechanism by which LTD is induced is largely
presynaptic (Nosyreva and Huber, 2005). EtOH (80 mM) did not affect the
induction of LTD, and this was not entirely surprising in light of the fact that EtOH
did not affect glutamate release in this brain region in previous studies in
immature animals (see Chapter 4; Fig. 6). However, it was surprising that we
observed a decrease in fEPSP responses (LTD) with no change in the pairedpulse ratio with AP5 and gabazine present. This is suggestive of both pre- and
postsynaptic LTD induction mechanisms. The presynaptic component identified
as a decrease in glutamate release by the paired-pulse ratios is potentially
NMDAR- and/or GABAAR-dependent, due to the lack of a change in the pairedpulse ratio when these receptors were blocked. The mechanism of the
postsynaptic LTD component remains unidentified; we thought it was likely
mGluR mediated, but LY failed to reduce LTD.
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Figure 8.1.1. Effects of acute EtOH on LTD induction in the CA1 region of P7-9 rats. (A) Time
course of fEPSP amplitude under identified conditions. LTD induction protocol was a 5Hz stimulus
for 3 min, and is represented by the gap in data points. (B) Time course of the paired-pulse ratio of
the LTD induction protocol. Bar indicates when 80 mM EtOH. (C) Bar graph illustrating the percent
decrease in fEPSPs normalized to the baseline (D) Percent change in the paired pulse ratio from
baseline. *=p<0.05.
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8.2. In vitro and in vivo effects of EtOH on MeCP2 levels,
phosphorylation, and BDNF mRNA.
8.2.1. Purpose of the experiment
Mutations in the gene that codes for the protein MeCP2 lead to Rett
syndrome. Alterations in brain derived neurotrophic factor (BDNF) levels have
been detected in animal models of FASD and Rett syndrome. The BDNF gene is
regulated by multiple factors, including MeCP2, and has been shown to be
induced by neuronal activity. One of the functions of MeCP2 is to repress
transcription by binding to methylated DNA sites, which is attenuated by MeCP2
phosphorylation at specific sites. We have previously shown that EtOH
potentiates neonatal CA3 hippocampal neuronal circuits resulting in increased
Ca2+ transients (Galindo et al., 2005). Therefore, we hypothesized that
increased EtOH-induced Ca2+ influx into the neonatal CA3 hippocampal region
leads to activity-dependent phosphorylation of MeCP2, leading to an increase in
BDNF mRNA levels.

8.2.2 Methods
Western Blotting
Brain slices (400 µm) were prepared as previously described (Chapter 4).
P4-6 brain slices were exposed to EtOH (50 mM; 30 min), Mg2+-free ACSF, and
Mg2+-free ACSF + NMDA (10 µm; 5 min exposure, followed by 25 min chase in
Mg2+-free ACSF) at 32ºC. Then the CA3 hippocampal region was
microdissected, and western blotting studies with CA3 homogenates were
performed. Primary antibodies against total MeCP2 (1:1000; Upstate
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Biotechnologies, Lake Placid, NY) and phospho-S421-MeCP2 (1:1000;
generously provided by Michael Greenberg, Harvard University) were used.
Samples (10 µg) were run on a precast 7.5% ready gel (Bio Rad, Hercules, CA).
Data are presented as the ratio of phospho-S421-MeCP2 over total MeCP2.
Western blot studies were normalized to the average intensity of 3 coomassie
stained bands or actin.

Immunohistochemistry and Microscopy
Brain slices were also paraformaldehyde fixed (4% PFA; 24-48 hrs),
sucrose protected (24 hrs), frozen in isopentane, and re-sectioned (12-14 µm
thick) using a cryostat. A pap pen was used to draw a circle around the tissue,
which was then permeabilized with 0.2% Triton-X-100 in PBS (~20 min) followed
by blocking in 2% bovine serum albumin (BSA) in PBS (30+ min). Then, the
primary antibody was applied in PBS w/ 2% BSA (Overnight at 4º C). Slides
were then rinsed in PBS-T 5x10min, followed by incubation with the secondary
antibody in 2% BSA at room temp for 2 hr. Slides were then rinsed in PBS-T
5x10 min, and counterstained with DAPI 1:500 (10-20 min). Slides were then
rinsed again, and 1-2 drops of Vectashield (Burlingame, CA) were applied and
cover-slipped. Microscopy images were taken with a Zeiss Meta 510m confocal
microscope at 40x.

Vapor exposure
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Vapor exposures were performed as previously described (chapter 5).
Neonatal rats were placed in vapor chambers; EtOH or air was perfused for 4
hrs/day starting at P2 and ending at P8. Samples were taken at P2, P4, P6 and
P8 (SECs= 40-80 mM).

RT-PCR
RT-PCR was used to measure BDNF mRNA levels in neonatal rats
exposed to air or EtOH using a vapor chamber exposure paradigm. mRNA was
isolated from the hippocampus using the Oligotex Direct mRNA Mini Kit (Qiagen,
Valencia, CA) according to the manufacturer’s protocol and stored at -80 oC prior
to use. The mRNA concentration was measured (OD 260 nm) using a
NanoDrop® ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington,
DE). cDNA synthesis reactions were performed using 10 ng mRNA, and RT-PCR
was performed as described (Caldwell et al., 2008). The relative quantification of
the target gene was determined using the 2-∆∆Ct method (Livak and Schmittgen,
2001).

8.2.3 Results
Figure 8.1 shows western blot data of p-MeCP2 and total MeCP2 levels in
the CA3 hippocampus microdissected from brain slices exposed to ACSF
(control), EtOH (50 mM; 30 min), Mg2+-free ACSF, and NMDA in Mg2+-free ACSF
(10 µm; 5 min followed by 25 min chase). Although there were large increases in
both p-MeCP2 levels (Fig. 8.2.1a) and total MeCP2 (Fig. 8.2.1b) levels these
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were not significantly different from baseline. However, when analyzed as a
ratio of p-MeCP2 to total MeCP2, EtOH caused a significant decrease in this
parameter (n=4; p<0.05 by one sample t-test v. 100%). As expected, NMDA
treatment let to a significant increase in the ratio (n=4; p<0.05 by one sample ttest v. 100%).
To address these results using a different method, we performed
immunohistochemistry. Figure 8.2.2 shows sample 40x images from (control),
EtOH, Mg2+-free ACSF, and NMDA in Mg2+-free ACSF conditions. No
differences with respect to control in DAPI staining (pixel intensity) were
observed for either the EtOH or NMDA conditions, indicating that cell counts
were not affected by these treatments (Fig. 8.2.3A,C). When analyzed for
changes in total MeCP2 levels, no significant effects of EtOH or NMDA were
detected (Fig. 8.2.3B,D). Similar results were obtained when data were
normalized to DAPI staining (Fig, 8.2.3E).
We then proceeded to study the effect of in vivo EtOH exposure on
MeCP2 levels. Rat pups and dams were exposed to EtOH vapor reaching SEC’s
of 40-80mM starting on P2, and continuing through P8 (Fig. 8.2.4A-B). Pup
weights were not significantly different by two-way ANOVA (n=3; Fig. 8.2.4C). As
shown in Fig. 8.2.5A-B, in vivo EtOH exposure did not consistently change
MeCP2 levels.
Samples were then processed for BDNF mRNA level analyses in the
laboratory of Dr. Caldwell (Fig. 8.2.6A-B). Exon VI represents the coding
sequence, and is representative of changes in all splice variants. There was a
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significant decrease in the total (exon VI) on all postnatal days tested for the
EtOH group compared to controls (n=3; p<0.05 by two-way ANOVA followed by
Bonferroni’s post hoc test). This significant difference on all postnatal days
tested was also seen with exon IV, and from P4-8 with exon V.
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Figure 8.2.1. Western blot data of in vitro CA3 microdissected slice
experiments. Effects of phospho-S421-MeCP2 (A) and total MeCP2 (B) levels
expressed as a percent change from ACSF controls.
Insets are
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Figure 8.2.2. Immunohistochemical images of total MeCP2 levels from resectioned brain slices. (A) ACSF control, (B) EtOH exposed slices (50 mM) (C)
control in Mg2+ free ACSF, and (D) NMDA (10 µM) in Mg2+ free ACSF. Red
staining (Cy3) is 2ry Antibody to total MeCP2, and blue DAPI nuclear DNA.
Images taken at 40x.
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Figure 8.2.3. Total MeCP2 levels are not altered with EtOH or NMDA exposure in
brain slices when analyzed by immunohistochemistry. Pixel intensity for DAPI
stained slides for control and EtOH (50 mM) treated slices (A), and control and
NMDA (10 µM) treated slices (C). Pixel intensity of total MeCP2 levels in control and
EtOH treated slices (B), and control and NMDA treated slices (D). Summary bar
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Figure 8.2.6. The effects of vapor EtOH exposure on BDNF mRNA levels from the
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8.2.4. Conclusions
Acute EtOH exposure significantly decreased the pMeCP2/total MeCP2
ratio, whereas the positive control condition with NMDA produced a significant
increase in the ratio. It appears as if the effect of EtOH was due to an increase in
total MeCP2 levels; however, this did not reach significance. We then addressed
this using a different method, immunohistochemistry. There was no change in
total protein MeCP2 protein levels with either EtOH or NMDA treatment, thus
indicating possible artifacts from western blotting techniques or slice experiment
protocols.
To further address this issue, we switched to an in vivo EtOH exposure
paradigm. Total MeCP2 levels were not different between control and EtOH
groups on any of the days tested (P2-8) coinciding with the
immunohistochemistry data, and further suggesting that there was no change in
MeCP2 levels with either acute or in vivo EtOH exposure.
This EtOH in vivo exposure paradigm also produced a decrease in BDNF
mRNA levels for the coding exon (VI) on all days tested. This was also seen for
exon IV and exon V (with the exception on P2 for exon V). This is interesting in
light of the fact that MeCP2, as well as other factors including CREB, regulate the
promoter of this exon IV. Future studies are needed to determine if EtOH affects
phosphorylation of MeCP2, and its role in the regulation of BDNF mRNA levels.
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8.3. The effects of electrode separation on the presynaptic volley
and fEPSP in field recordings in P7-9 rat pups.
8.3.1. Purpose of the experiment
In recordings from neonatal animals, we found it difficult to separate out
the presynaptic volley from the field response. This experiment series address
two issues: (1) does increased distance result in increased separation between
the volley and fEPSP response (as it does in more mature animals), and (2)
input-output curve data showing the effect of recording distances on fEPSP
amplitude.

8.3.2 Methods
Recordings of AMPAR-mediated fEPSPs were performed as described in
chapter 4. Briefly, the ACSF contained blockers of NMDA- and GABAA receptors
(AP5 50 µM, and gabazine 10 µM). Recordings were performed by placing the
stimulating electrode in the vicinity of the Schaffer collaterals, and first placing the
recording electrode ~400 µm away (distance 2) and then ~200 µm away
(distance 1). Input-output curves were collected at both recording locations. The
reference to calculate the separation distance was the diameter of the outer pole
of the stimulating electrode (125 µm)

8.3.3 Results
Figure 8.3.1A-B shows that with increasing distances between the
stimulation and recording electrodes, there is a decrease in the amplitude in
responses. Separation of the presynaptic volley with increasing
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recording/stimulating electrode separation could not be assessed because the
volley became undetectable at the ~400 µm separation distance. In addition, the
input-output curves showed a decrease in fEPSP amplitude at this distance (Fig.
8.3.1C; n=3; p<0.05 by two-way ANOVA).

8.3.4 Conclusions
There should be better separation between the volley and fEPSP with
increased distances between the recording/stimulating electrodes; however, the
small amplitude of the volley and fEPSP response at greater inter-electrode
distances made it difficult to assess this possibility. Moreover, the small fEPSP
amplitude at greater separation distances would make it difficult to perform
pharmacological experiments with agents that inhibit these responses, such as in
the case of EtOH.
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Figure 8.3.1. Effects of electrode separation on fEPSP responses in the CA1
hippocampus of P7-9 rat pups. (A) Pairs of recordings of AMPAR-mediated fEPSPs
obtained with 2 different electrode separation distances in presence of NMDA and
GABAA receptor blockers (AP5: 50 μM and gabazine 10 μM) using increasing stimulus
intensities. (B) Representation of measured distance between stimulation and recording
electrode. (C) Input-output curve data for the different recording distances. (Stimulus
duration 75 μs; scale bar is 0.1 mV/20 ms)
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8.4. BS3 crosslinking pilot study addressing AMPAR (GluR1-4)
trafficking with the adenylyl cyclase activator, forskolin in the
microdissected CA1 hippocampus from P5 rat pups.
8.4.1 Purpose of the experiment
This was a pilot study to determine the feasibility of studying changes in
the surface expression of AMPARs in neonatal rat pups. Studies have shown
that LTP mechanisms involve increased surface expression of AMPARs, a
process that depends on PKA activity (Yasuda et al., 2003; Grosshans et al.,
2002).

8.4.2 Methods
Brain slices (400 µm) were prepared as previously described in chapter 4.
After a recovery period, half of the slices were incubated in forskolin (50 µM) for 5
min (32ºC for all incubations) followed by a 20 min chase in standard ACSF. The
other halves were incubated in ACSF for 25 min. Then, slices were placed into
air-tight scintillation vials containing cold oxygenated ACSF with or without BS3 (1
mg/ml), a membrane impermeable crosslinking agent. These were then
incubated at 4ºC to stop any further trafficking for 45 min with gentle shaking.
Then slices were washed 4x in cold oxygenated ACSF containing 20 mM Tris
(pH 7.5). The CA1 regions from brain slices were microdissected, sonicated in
75 µL homogenization buffer buffer (20 mM HEPES, 0.5% Triton-X, 0.5 M NaCl,
10 mM NaF, 2 mM NaOrthovandronate, 0.2 mM EDTA, 1 mM DTT), then frozen
in dry ice-EtOH cooled isopentane. Samples were run using western blotting
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protocols as previously described in Appendix 8.2.2. Data were normalized to
actin.

8.4.3 Results
BS3 is a cell-impermeable crosslinking agent that results in a smear
(surface expressed AMPARs crosslinked to other protiens) on the top of the
western blot, and a clear band of non-crosslinked AMPARs (internal pool). We
used this technique to determine the forskolin-induced change in the internal pool
normalized to total AMPAR levels in non-BS3 treated slices. Comparisons
between control and forskolin treated conditions are shown in figure 8.4.
Forskolin caused a significant decrease in the GluR1 internal pool, suggesting
that it increased surface expression of this subunit (fig. 8.4B). However, it did not
affect the internal pool for other GluR subunits.

8.4.4. Conclusions
It was surprising that forskolin only affected trafficking of GluR1, as the
surface expression of GluR2 and/or GluR4-containing AMPARs has been shown
to increase in an activity dependent manner. In fact, it is thought that GluR4 (or
GluR2 lacking AMPARs) AMPARs are trafficked to the synapse early during
stimulation and these are replaced by GluR2 containing AMPARs; however, we
did not see significant surface trafficking of the GluR4 AMPAR subunits (Zhu et
al., 2000). It is of important note that this was only a pilot study and further
investigations are needed to accurately assess this issue.
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Figure 8.4.1. Pilot experiment addressing the effects of forskolin on GluR trafficking in the
microdissected CA1 hippocampal region of P5 rat-pups. (A) Sample western blots for each GluR
subunits under control, control BS3 treated, forskolin (50 µM), and forskolin BS3 treated. (B)
Percent change in the internal pool of forskolin treated slices normalized to 100% of control.
*p<0.05, by one sample t-test v. 100.
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8.5. Paired-pulse ratios of experiments presented in chapter 4,
further addressing the acute effects of EtOH in perforated-patch
and whole cell experiments exhibiting paired-pulse facilitation in
the CA1 hippocampus.
8.5.1 Purpose of the experiment
This was a re-analysis of data addressing the effects of EtOH on the
paired-pulse ratio in experiments that only demonstrated paired-pulse facilitation,
as EtOH could differentially affect the PPR under conditions of paired-pulse
facilitation vs. depression.

8.5.2 Methods
Methods for slice preparation, experimental procedures and data
collection are as described in chapter 4 (Fig. 6). Data re-analysis consisted of
pooling paired-pulse ratios for whole-cell (n=4) and perforated-patch (n=4)
experiments. Then a selection criterion was set such that only experiments
demonstrating paired-pulse facilitation were selected (i.e. those having a PPR >
1; PPR defined as fEPSP2 /fEPSP1) which resulted in the exclution of 2
recordings from the perforated-patch group. Data was analyzed by one sample
t-test from the average of baseline and washout from 100%.

8.5.3 Results
In pooled whole-cell and perforated-patch recordings, 6/8 neurons
demonstrated paired-pulse facilitation. In these recordings acute EtOH (80 mM)
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application did not affect the paired-pulse ratio (NS by one-sample t-test vs.
100%).

8.5.4 Conclusions
These data indicate that glutamate release is not affected by acute EtOH
application when the paired-pulse ratio is limited to the facilitation condition

PPR (of Whole cell
and Perforated Patch experiments)

(chapter 4).

1.5
1.4
1.3
1.2
1.1
1.0
0.9
Baseline

EtOH

Washout

Figure 8.5.1. Whole-cell and perforated-patch experiments addressing the
acute effects of EtOH (80 mM) on the paired-pulse ratio in CA1 hippocampal
fields or neurons demonstrating paired-pulse facilitation.
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8.6. Does contamination of presynaptic volleys by the rising
phase of fEPSPs affect volley amplitude and or time-to-peak?
8.6.1 Purpose of the experiment
In a subset of recordings, there was a reduction in the presynaptic volley
amplitude after application of EtOH. The question being addressed is: Do EtOHinduced changes in the amplitude of postsynaptic field responses influence the
amplitude or the time-to-peak of the fiber volley?

8.6.2 Methods
Methods for slice preparation, experimental procedures and data
collection were as described in chapter 4. Recordings of AMPAR-mediated
fEPSPs were performed in gabazine (10 µM), AP5 (50 µM). fEPSPs were
inhibited by NBQX (10 µM), and the presynaptic volley was inhibited by TTX (0.5
µM). Data was analyzed by unpaired t-test.

8.6.3 Results
Figure 8.6 shows that NBQX-induced blockade of the fEPSP decreased
the fiber volley amplitude by approximately 10% without changing the volley timeto-peak. Partial inhibition of the fEPSP by EtOH, produced a significantly
smaller decrease in volley amplitude, with the volley time-to-peak being
unaffected as in the case of the NBQX treatment condition.

8.6.4 Conclusions
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These data indicate that fEPSPs contaminated the presynaptic volley
under our recording conditions. Surprisingly, blockade of the fEPSP did not
change the volley time-to-peak as it would have been expected because only
part of the rising phase of the fEPSP overlaps with the volley. Instead, the
amplitude of the volley decreased when the fEPSP amplitude decreased. The
significant difference between the NBQX and EtOH groups indicates that there is
a relationship between the magnitude of inhibition of the fEPSP and effects on
the fiber volley. The overall conclusion from these experiments is that the fibervolley that was recorded under our experimental conditions should be addressed
as a “contaminated” volley.
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Figure 8.6.1. A decrease in the postsynaptic fEPSP amplitude is associated with a decrease in the
amplitude (but not the time-to-peak) of the fiber volley. (A) Sample trace of an AMPAR-mediated
fEPSP recording showing the effect of NBQX (10 µM) and TTX (0.5 µM). Scale bar 0.2mV/5ms. (B)
Sample trace of AMPAR-mediated fEPSP recording showing the effect EtOH (80 mM). Scale bar
0.5mV/5ms. (C) Bar graphs of the normalized the volley amplitude for the NBQX and EtOH groups.
(D) Bar graph of the normalized time-to-peak for NBQX and EtOH. *p<0.05 by unpaired t-test.
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8.7. Repeated vapor EtOH exposure from P2-P5 does not affect
AMPAR GluR1-4 subunit expression by western blotting
techniques in the microdissected CA1 hippocampal region of P5
rat pups.
8.7.1 Purpose of the experiment
The purpose of this study was to further confirm the lack of a functional
change in AMPAR-mediated fEPSPs described in chapter 6 using biochemical
techniques.

8.7.2 Methods
Vapor EtOH exposure and the preparation of brain slices occurred exactly
as described in chapter 6. SECs were 45-64 mM on P5 when acute brain slices
were prepared. After a recovery period of 90-120 min, the CA1 hippocampal
region from brain slices were microdissected out in PBS or ACSF at 4ºC, and
immediately placed in homogenate buffer, and run using western blotting
techniques as described in 8.2.2. Antibodies for GluR1-4 were from Millipore
(Billerica, MA) and used at 1:1000 for GluR1,3,4 and 1:2000 for GluR2.
8.7.3 Results
Vapor EtOH exposure paradigm did not affect the expression of GluR1-4
levels in the CA1 hippocampal region (NS by one-sample t-test from 100% of
control; n=3)
8.7.4 Conclusions
These data further support a lack of functional change in AMPARmediated fEPSP as described in chapter 6.
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Figure 8.7.1. Repeated EtOH vapor exposure from P2-P5 (BEC 45-64 mM)
does not affect AMPAR levels in the microdissected CA1 region of the
hippocampus. (A) After EtOH exposure on P5, brain slices were prepared,
allowed to recover for 90-120 min, and the CA1 hippocampal region was
microdissected. (B) Sample blots showing GluR1-4 bands from control and
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AMPAR GluR1-4 levels as a % of control.
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8.8.1. Reanalysis of NMDAR-mediated fEPSP input-output
curves normalizing data to the presynaptic volley demonstrated
no difference between control and EtOH exposed animals
8.8.1 Purpose of the experiment
The purpose of this reanalysis was to investigate the presynaptic effects of
developmental EtOH exposure, and address uncertainty pertaining to the lack of
a change in synaptic strength (NMDAR- and AMPAR-mediated).
8.8.2 Methods
Data was obtained and collected as performed in chapter 6.
8.8.3 Results
There was no significant difference in the input-output curves when the
fEPSP amplitude was normalized to the presynaptic volley in brain slices from
control and EtOH exposed P7-9 rat pups (Fig. 8.8.1).
8.8.4 Conclusions
These data further support that the long-lasting (at last 1-7 hrs)
impairments in synaptic plasticity are not a result of changes in synaptic efficacy
for NMDAR-mediated responses. However, due to the difficulty in analyzing the
presynaptic volley in AMPAR-mediated experiments, it remains a possibility that
input-output curves for AMPARs could be affected. These parameters must be
kept in mind when interpreting data pertaining to synaptic strength.
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Figure 8.8.1. NMDAR-mediated input-output curves normalized to the presynaptic volley are
not different between control and EtOH exposed animals measured in the CA1 hippocampal
region in brain slices from P7-9 rat pups. (A) NMDAR-mediated fEPSPs normalized to the
presynaptic volley. Data were not significantly different when analyzed by two-way ANOVA.
(B) Plot of fEPSP amplitude v. volley amplitude. Linear regression for control (p<0.05; r2=0.88)
and EtOH (p<0.05; r2=0.87) were not significantly different for the slope of the line (p-0.19;
F=1.67)
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